Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


DEVICES TRANSFERRING FLUIDS FROM WITHIN ONE AREA OF BODY TO ANOTHER (E.G., SHUNTS, ETC.)

Subclass of:

604 - Surgery

Patent class list (only not empty are listed)

Deeper subclasses:

Class / Patent application numberDescriptionNumber of patent applications / Date published
604009000 With flow control means (e.g., check valves, hydrocephalus pumps, etc.) 188
Entries
DocumentTitleDate
20130030350Devices and Methods for Anchoring an Endoluminal Sleeve in the GI Tract - An endoluminal sleeve device for internally lining a section of the GI tract, comprises a sleeve configured for deployment inside a duodenum, the sleeve having walls of a flexible material defining a sleeve lumen, a proximal end defining a proximal lumen opening, and a distal end defining a distal lumen opening, an anchoring component having a slender transport configuration and a bulky deployed configuration, wherein the anchoring component is locatable at a distance from the proximal sleeve end and connected thereto by an elongated tether.01-31-2013
20130030349Side-by-side lacrimal intubation threader device - A device for inserting a flexible silicone intubation stent into the lacrimal drainage system of a patient. The device has an oblong hollow semi-rigid probe having the flexible stent releasably secured to its blunted distal end. The probe and stent are oriented in a side-by-side configuration for endwise insertion into the punctum. The stent can be temporarily secured to the distal end of the probe by engaging the probe's distal opening. The stent can be detached by injecting a pressurized fluid through the channel of the probe thereby forcing the distal end of the stent to pop off. The proximal extremity of the stent is secured in the patient by an integrated or separate punctal anchor.01-31-2013
20100087774OCULAR IMPLANT WITH ANCHORING MECHANISM AND MULTIPLE OUTLETS - Devices and methods for treating ocular disorders are disclosed. One ocular implant, has a substantially straight, rigid, elongate body. The body has a self-trephinating distal portion that narrows toward a distal end, and at least one inlet that communicates with at least one inner lumen that communicates with a plurality of outlets. The lumen has a sufficient length to extend from an anterior chamber of an eye to a physiologic outflow pathway. An anchor member extends from the implant.04-08-2010
20100160848Ureteral Stent - In some embodiments, a ureteral stent includes an elongate member having a first portion and a second portion, which is coupled to the first portion. The first portion of the elongate member is configured to be disposed within a kidney of a patient. The second portion of the elongate member, which has a sidewall that defines a lumen, is configured to deliver fluid from a first location of the sidewall of the second portion to a second location of the sidewall of the second portion via capillary action. The second portion of the elongate member is configured to be disposed within at least one of a bladder and a ureter of the patient.06-24-2010
20100121247Dialysis Graft with Thromboses Prevention Arrangement - A dialysis graft includes an artery connection section having one end connected to an artery; and a vein connection section having both ends connected to two sections of a vein respectively. Diameter of either end of the vein connection section is equal to that of the corresponding section of the vein. The other end of the artery connection section is integrally formed with the vein connection section and communicates therewith. An enlargement for preventing stenosis and thromboses is formed at the connection of the artery connection section and the vein connection section. The artery connection section is inclined at an acute angle with respect to the vein connection section at the connection and the enlargement is formed at the obtuse angle side of the connection.05-13-2010
20100076365METHOD AND APPARATUS FOR ACCESSING THE WALL OF A VASCULAR STRUCTURE OR OTHER BODY LUMEN WHILE SIMULTANEOUSLY PROVIDING ZONE ISOLATION AND FLUID BYPASS CAPABILITY - Apparatus and method for accessing the wall of a body lumen while simultaneously providing zone isolation and fluid bypass capability, the apparatus comprising: 03-25-2010
20130079701Methods and Apparatus for Delivering Ocular Implants Into the Eye - A method of deploying an ocular implant into Schlemm's canal of a human eye including the following steps: inserting a distal tip of a delivery tool within an anterior chamber of the eye through trabecular meshwork of the eye into Schlemm's canal of the eye; and advancing an ocular implant through a curved portion and a distal opening of the delivery tool to place a body portion of the ocular implant in Schlemm's canal and an inlet portion of the ocular implant in the anterior chamber.03-28-2013
20130035628METHODS AND SYSTEMS FOR TREATMENT OF ACUTE ISCHEMIC STROKE - Described are methods and systems for transcervical access of the cerebral arterial vasculature and treatment of cerebral occlusions, including ischemic stroke. The methods and devices may include methods and devices which may provide aspiration and passive flow reversal, those which protect the cerebral penumbra during the procedure to minimize injury to brain, as well as distal catheters and devices to remove an occlusion. The methods and devices that provide passive flow reversal may also offer to the user a degree of flow control. Devices and methods which provide a way to securely close the access site in the carotid artery to avoid the potentially devastating consequences of a transcervical hematoma are also described.02-07-2013
20130079699Method of draining autologous bodily fluid into intraosseus space - A method for draining autologeous biological fluid includes positioning a catheter to receive the autologeous biological fluid from a selected site in a mammalian body with the end of the catheter adapted to receive such fluid. An output end of the catheter is positioned into the intraosseus space. The fluid is transmitted through the catheter to intraosseus space thereby draining the selected site from the autologous biological fluid.03-28-2013
20130079700COMPOSITE PROSTHETIC SHUNT DEVICE - In accordance with certain embodiments of the present disclosure, a composite prosthetic device is described. Generally, the device comprises at least one layer of ePTFE, at least one thermoplastic elastomeric component, and a frame. In certain aspects, the thermoplastic elastomeric component penetrates the microstructure of the at least one layer of ePTFE, providing a means for varying the porosity of the ePTFE.03-28-2013
20130041305ARTERIAL SHUNT - Various embodiments of the present invention are directed toward an arterial shunts for use during vascular surgery. Some embodiments are useful during an endarterectomy, and may be configured for use with specific arteries (e.g., carotid). Additional embodiments may be configured with a filter to prevent clots or plaque from traveling through the shunt, and with a flow meter to provide indication of how much or how little blood is actually passing through the shunt.02-14-2013
20130041306Therapeutic method for treatment of hypertension - A long-term implantable arterio-venous shunt device or creation of a fistula is provided that can be used as a therapeutic method for treating chronic obstructive pulmonary disease (COPD). The shunt device is implanted between an artery and a vein, preferably between a peripheral artery and the inferior vena cava. The shunt device and method of creating a fistula increases cardiac output and decreases the systemic vascular resistance and allows a blood flow rate through the shunt device of at least 5 ml/min after the implantation. Based on the effects of the method and device to the respiratory, cardiac and circulatory system, the method and device are beneficial as a therapy to patients with problems or conditions related to these systems.02-14-2013
20100042039CEREBROSPINAL FLUID SHUNT HAVING LONG TERM ANTI-OCCLUSION AGENT DELIVERY - A shunt for at least partial implantation into a patient that includes an elongated conduit having at least one lumen therethrough and a second lumen concentric about the first lumen along at least part of the first lumen, that includes a proximal end for receipt of bodily fluids for flow through the shunt and a distal end for discharge of the bodily fluids from the shunt, and a long term source of at least one occlusion resistant agent, wherein said at least a portion of the at least one occlusion resistant agent can permeate through at least a portion of the elongated conduit. The invention also includes kits and systems.02-18-2010
20090156977URINARY STENT - A urinary stent includes an elongate member that defines a lumen extending therethrough and that is configured to be disposed at least partially within a prostatic portion of a urethra of a patient. The elongate member includes a collapsible portion disposed at a proximal end portion of the elongate member. The collapsible portion has a first configuration in which an outer perimeter at a proximal end of the collapsible portion is substantially equal to an outer perimeter of a remaining portion of the elongate member and a second configuration in which the outer perimeter at the proximal end of the collapsible portion is smaller than the outer perimeter of the remaining portion of the elongate member.06-18-2009
20100106073METHOD OF MONITORING INTRAOCULAR PRESSURE AND TREATING AN OCULAR DISORDER - The invention discloses a trabecular stent and methods for treating glaucoma. The stent may incorporate an intraocular pressure sensor comprising a compressible element that is implanted inside an anterior chamber of an eye, wherein at least one external dimension of the element correlates with intraocular pressure. In some embodiments, the sensor may be coupled to the stent. Also disclosed are methods of delivery of the stent and the sensor to the eye.04-29-2010
20090124955Device for delivery of antifibrotic agents & method - An ophthalmological device comprises an implant member carrying an antifibrotic agent that is released slowly over a prolonged period when inserted into a wound in an eye produced by surgery. The member is placed in the vicinity of a wound created during the surgery to inhibit inflammatory cell proliferation, thereby preventing the growth of fibrous tissue after the eye surgery.05-14-2009
20090043242INSTRUMENTS AND METHODS FOR IMPLANTING CORNEAL IMPLANT VIA EXTRA-AND INTRA-CAMERAL ROUTES - A method of implanting a transcorneal shunt into a cornea, the shunt having a head and a foot, each having a hole therein, the method including the operations of engaging an insertion tool with a foot hole of the shunt; making an entry incision in the cornea; inserting the shunt, while still engaged with the insertion tool, through the entry incision; making an implant incision in the cornea; inserting the head of the shunt through the implant incision to position and seat the shunt; and releasing the shunt from the insertion tool.02-12-2009
20130090590Methods and Apparatus for Treating Obesity and Diabetes - Provided herein are methods and shunt devices for treating diabetes and obesity. Methods and shunt devices promote stimulation of secretion of intestinal L-cells and other enteroendocrine cell types. Enteroendocrine secretion is stimulated directly or indirectly by shunting bile and/or pancreatic secretion to segments of the gut more distal than would normally occur. The shunt device may be a flexible catheter that is impervious to such secretions, with a proximal end draining the pancreatic/bile duct, and a distal end residing distally within the lumen of the small or large intestine. The shunt may be inserted with minimally invasive techniques, such as by endoscopy or laparoscopy.04-11-2013
20110009802Surgical Methods, Devices, and Kits - Methods, devices, and kits for creating bloodstream access in patients are provided. A patient's vessel is accessed surgically and blood flow is stopped. A short incision is made through the wall of one side of the vessel where the blood flow was stopped. A puncturing instrument is pushed through the incision across the lumen and through the vessel wall at a site opposite the incision. After the puncturing instrument is removed, a vessel wall traversing device which can be shaped like a blunt-ended nail with a hollow shank and a head of a larger diameter than the shank is inserted in the puncture hole blunt end first such that the shank traverses the puncture hole with the blunt end being positioned exterior to the outer surface of the vessel and the head of the device abutting inner surface of the vessel at the puncture hole. The portion of the shank that projects outwards from the vessel wall is connected to one end of a flexible cannula, and the other end of the cannula is passed through the surrounding tissue such that the end of the cannula opposite the vessel wall traversing device protrudes through the skin of the patient. A portion of the cannula protruding from the patient is clamped off, the incision is closed, and blood flow is restored to the vessel. Blood within the vessel is than accessible via the portion of the cannula protruding from the patient.01-13-2011
20110009801DEVICES AND METHODS FOR TREATMENT OF OBESITY - A device for isolating tissue in the digestive tract including a biocompatible portion having a surface sized to cover the tissue to be isolated and also includes a plurality of micro-anchors attached to the biocompatible portion and extending from the surface, the micro-anchors sized to penetrate the mucosa of the tissue. A method for isolating tissue in the digestive tract in which an isolation element is delivered to a desired location in the digestive system; the isolation element having fixed thereto a plurality of micro-anchors. The method also includes attaching the isolation element to tissue at the desired location by causing the micro-anchors to penetrate the mucosa of the tissue.01-13-2011
20130072848Threaded lacrimal drainage tube method - A threaded lacrimal bypass drainage device uses a threaded cannula or tube for greater axial friction and adjustability. The tube has a keyed flange for engagement by a keyed screwdriver-type tool having a trocar coaxially engaging the tube and providing a distal cutting blade. A removable, coaxial, biocompatible washer discourages tissue overgrowth of the tube immediately after emplacement. One or more radial drainage holes formed near the distal end of the tube overcome axial blockages. Adjustments to the axial position of the tube can be readily made during successive office visits by the patient.03-21-2013
20090124956Polyester compositions, methods of manufacturing said compositions, and articles made therefrom - Crosslinked polymer compositions have backbones with first and second divalent saturated aliphatic moieties, a divalent saturated aliphatic secondary alcohol moiety, and a trivalent saturated aliphatic moiety. Hydrolytically labile ester bonds joined together these moieties. These polyesters may be polycondensation reaction products of a diol, a triol and a diacid. A molar ratio of the first divalent saturated aliphatic moiety, the divalent saturated aliphatic secondary alcohol moiety, and the trivalent saturated aliphatic moiety to the second divalent saturated aliphatic moiety is in the range of about 0.85 to about 1.5. Preferably, these polyesters are non-cytotoxic, biocompatible, bioabsorbable, or exhibit shape memory behavior with at least one transition temperature of greater than about 30° C. and less than about 100° C. and most preferably exhibit each of these qualities. The compositions may be adapted for a wide variety of uses, including medical applications.05-14-2009
20120116286INTESTINAL SLEEVES AND ASSOCIATED DEPLOYMENT SYSTEMS AND METHODS - An intestinal implant includes a proximal anchor self-expandable from a radially compressed position to a radially expandable position for engagement with a wall of the intestinal lumen and a flexible sleeve coupled to the anchor. The sleeve is implanted with the anchor downstream from the pylorus and the sleeve extending further downstream through the intestinal lumen.05-10-2012
20090234267METHOD AND DEVICE FOR EASY ACCESS TO VASCULAR GRAFT CANNULATION SITES - The present invention relates to a polymeric venous implant wherein at least a portion of the graft is made from a UV fluorescing polymer which allows the user to see the graft during access use. This allows the graft to be injected much easier by the ability of the technician to find the graft or a stick site on the graft.09-17-2009
20130165840FLUID COMMUNICATION DEVICE AND METHOD OF USE THEREOF - A fluid communication device is configured to provide fluid flow between first and second chambers separated by tissue. The fluid communication device includes a member configured for insertion through and engagement of the tissue. The member includes a first opening near a first end of the member for fluidic communication with the first chamber and a second opening near a second end of the member for fluidic communication with the second chamber, the fluid member including a fluid passage that provides fluidic communication between the first and second chambers. The fluid communication device is configured to be positioned with the eye to provide fluid communication between an anterior chamber of the eye and Schlemm's canal.06-27-2013
20130165841SYSTEMS AND METHODS FOR TREATMENT OF OBESITY AND TYPE 2 DIABETES - The present invention provides systems and methods for treating and controlling obesity and/or type II diabetes. In one aspect of the invention, an internal bypass device includes gastric and duodenal anchors coupled to each other and positioned on either side of the pylorus and a hollow sleeve designed to extend from the pylorus through at least a proximal portion of a patient's small intestine. The gastric and duodenal anchors are movable between collapsed configurations for advancement through the esophagus and an expanded configuration for inhibiting movement of the anchors through the pyloric sphincter. Thus, the bypass device can be placed and removed endoscopically through the patient's esophagus in a minimally invasive outpatient procedure and it is “self-anchoring” and does not require invasive tissue fixation within the patient's GI tract, thereby reducing collateral tissue damage and minimizing its impact on the digestive process.06-27-2013
20110028883GLAUCOMA TREATMENT DEVICE - Methods and devices are adapted for implanting into the eye. An incision is formed in the cornea of the eye and a shunt is inserted through the incision into the anterior chamber of the eye. The shunt includes a fluid passageway. The shunt is passed along a pathway from the anterior chamber through the scleral spur of the eye into the suprachoroidal space and positioned in a first position such that a first portion of the fluid passageway communicates with the anterior chamber and a second portion of the fluid passageway communicates with the suprachoroidal space to provide a fluid passageway between the suprachoroidal space and the anterior chamber.02-03-2011
20080294084Method and device for temporary emergency vessel anastomoses - A device and method for achieving hemostasis and leakage control in vascular structures and other body ducts or vessels in an emergency room or trauma situation. The device has at least one shunt that contains an obturator on an end of the shunt. The shunt is inserted into a damaged vessel or lumen for sealing the leak or hemorrhage. Two shunts that both contain obturators on one of their ends can be inserted into two different vessels or lumens when the vessel or lumen has been severed. The obturators allow for the improved ease of insertion into the vessel or lumen. The two shunts are then releasably attached to restore fluid communication through the vessel or lumen. The shunt is placed temporarily within the patient and then removed when definitive repair can be achieved by a qualified physician.11-27-2008
20120101423DEVICE AND METHOD FOR ESTABLISHING AN ARTIFICIAL ARTERIO-VENOUS FISTULA - A shunt rivet for implementation in the aorta and inferior vena cava to treat chronic obstructive pulmonary disease, and a method of treating chronic obstructive pulmonary disease.04-26-2012
20120022426System and method for embolic protection - A balloon catheter system distinguishing a proximal balloon catheter system and a distal balloon catheter is provided. The proximal balloon catheter system has a first and a second catheter. These two catheters are positioned side-by-side over at least part of the longitudinal area of their outer surfaces, and they are detachably connected to each other. A first inflatable member is attached to the first catheter near the distal end of the first catheter. The distal balloon catheter distinguishes a catheter part with a distal end and a proximal end, and an exchange rod attached near the proximal end of the catheter part. The catheter part has a second inflatable member encircling the outer surface of the catheter part. The balloon catheter system can be used for example in methods of isolating a segment of a vessel, generating reversal fluid flow and creating an in-vivo shunt with a balloon catheter.01-26-2012
20110282263Subdural Drainage Catheter with Flow Restoration Mechanism - A subdural drainage system includes (a) a subdural drainage device having an opening formed therethrough, said subdural drainage device having an upper portion, a body portion, and a lower portion; (b) a housing having an upper portion and lower portion, with said housing connected to said subdural drainage device; said housing movable between (i) a first configuration and (ii) a second configuration; and (c) a stylet positioned inside said housing, said stylet having an upper portion and a lower portion and configured such that said stylet is moved between (i) a withdrawn position with said stylet withdrawn from a portion of said subdural evacuation port device, and (ii) an extended position with said stylet extending through said subdural drainage device such that blockages are disrupted in the subdural drainage device when said housing is moved between said first and second housing configurations; and (e) an external drain opening formed on either said subdural drainage device or said housing.11-17-2011
20120197175METHODS, SYSTEMS AND APPARATUS FOR RELIEVING PRESSURE IN AN ORGAN - The invention generally relates to shunts in which at least a portion of the body includes a drug.08-02-2012
20110301523GASTROINTESTINAL ANCHOR COMPLIANCE - A collapsible gastrointestinal anchor can be characterized in various embodiments by a radial force of about 0.1 Newtons (N) or greater at a compressed diameter of 25 millimeters (mm); by an average spring rate of about 13 Newtons/meter (N/m) or greater in a range of motion between a relaxed diameter and a compressive elastic deformation diameter; or by a radial force over the range of motion of about 0.1 N or greater. Typically, the anchor can be adapted to be retained within a subject's intestine, more typically in the duodenum, or particularly in the duodenal bulb just distal to the pylorus.12-08-2011
20090062717GASTROINTESTINAL IMPLANT AND METHODS FOR USE - Methods and devices for modifying the location at which bodily fluids interact with nutrients in a gastrointestinal tract having a conduit having a first end and a second end, the first end configured to divert bodily fluids from an entrance within a gastrointestinal tract to a location downstream from the entrance, and means for attaching the second end to the entrance.03-05-2009
20110295181IMPLANTABLE AND REMOVABLE CUSTOMIZABLE BODY CONDUIT - An apparatus and method are provided to treat a stenosis. A delivery device is provided that has an elongate tubular member coupled therewith. The elongate tubular member has an outside surface that is configured to prevent adherence of in vivo matter. The tubular member has a proximal end and a distal end and is reinforced along its length to maintain open lumen under a transverse load. The tubular member is placed in the vasculature such that the distal end of the elongate tubular member is disposed distal of a stenosis. The proximal end of the elongate tubular member is disposed inside the vessel, preferably at a location proximal of the stenosis. Thereafter, after a therapeutic period, the elongate tubular member is removed intact.12-01-2011
20110295180INTESTINAL BRAKE INDUCING INTRALUMINAL THERAPEUTIC SUBSTANCE ELUTING DEVICES AND METHODS - Methods and devices create an intestinal braking effect, are non-invasive or minimally invasive, and may be reversible. These methods and devices are accomplished via stabilized implantable systems, and ingestible pills. In one embodiment, the implantable system comprises a device delivering a therapeutic substance to a target location within the gastrointestinal tract of a patient in order to initiate an intestinal braking effect which would promote sensations of satiety and stimulate excess weight loss for the patient.12-01-2011
20110295178Intestinal Brake Inducing Intraluminal Therapeutic Substance Eluting Devices and Methods - Methods and devices create an intestinal braking effect, are non-invasive or minimally invasive, and may be reversible. These methods and devices may be accomplished via stabilized implantable systems and ingestible pills. In one aspect, a method of inducing satiety includes implanting an implant within a lumen of a gastrointestinal tract and retaining a portion of chyme that flows by the implant within a body of the implant. The method further involves re-releasing the retained chyme from the implant into the gastrointestinal tract at a predetermined rate slower than a rate caused by natural peristalsis.12-01-2011
20120022425Alleviate back pain with lactic acid inhibitors - The intervertebral disc is avascular. Nutrients and waste are diffused through adjacent vertebral bodies into the disc. As we age, calcified layers form between the disc and vertebral bodies, blocking diffusion of nutrients, oxygen and pH buffer in blood. Under anaerobic conditions, lactic acid is produced, irritating nerve endings and causing nonspecific pain. In addition, the disc begins to starve and flatten. The weight shifts abnormally from disc to the facet joints causing strain and back pain.01-26-2012
20100114006GLAUCOMA DRAINAGE SHUNTS AND METHODS OF USE - A method of treating glaucoma in an eye utilizing an implanted shunt having an elastomeric plate and a non-valved elastomeric drainage tube. The plate is positioned over a sclera of the eye with an outflow end of the elastomeric drainage tube open to an outer surface of the plate. An inflow end of the drainage tube tunnels through the sclera and cornea to the anterior chamber of the eye. The drainage tube collapses upon initial insertion within an incision in the selera and cornea, or at a kink on the outside of the incision, but has sufficient resiliency to restore its patency over time. The effect is a flow restrictor that regulates outflow from the eye until a scar tissue bleb forms around the plate of the slunt. The plate desirably has a peripheral ridge and a large number of fenestrations, and a longer suturing tab extending from one side of the plate to enhance visibility and accessibility when suturing the shunt to the selera.05-06-2010
20100056977Trans-corneal shunt and method - A method for relieving pressure within the eye in the treatment of glaucoma comprising inserting an extremely thin flat trans-corneal drainage shunt, having no detrimental cap or footplate, within a self-sealing incision made by a keratome knife within the cornea at the limbus, the drainage shunt having extremely small pores formed therein for the controlled transport of aqueous fluid from an anterior portion of the eye to the tear film on the surface of the eye while deterring bacteria from entering the eye, and fixing the position of the trans-corneal shunt in position within the cornea by means of a suture. The shunt can be tapered for preventing an unacceptable degree of intrusion of the shunt into the anterior portion of the eye. The trailing edge portion of the shunt is wide relative to other portions of the shunt, thereby facilitating grasping of the shunt when desired.03-04-2010
20120035525OCULAR IMPLANT WITH FLUID OUTFLOW PATHWAYS HAVING MICROPOROUS MEMBRANES - Disclosed are devices, methods and systems for treatment of eye disease such as glaucoma. Implants are described herein that enhance aqueous flow through the normal outflow system of the eye with minimal to no complications. The implant can include reversibly deformable portions that have a plurality of openings layered, covered or otherwise spanned by an elastomeric film or membrane having micropores. The micropores allow for fluid flow out of the implant while inhibit cellular infiltration and blockage of the openings.02-09-2012
20120109040COMBINED TREATMENT FOR CATARACT AND GLAUCOMA TREATMENT - A method is provided for treatment of cataract in combination with a glaucoma procedure while maintaining the intraocular pressure by permitting aqueous to flow out of an anterior chamber of the eye through a surgically stented pathway. A trabecular stent is adapted for implantation within the trabecular meshwork of an eye such that intraocular liquid flows controllably from the anterior chamber of the eye to Schlemm's canal, bypassing the trabecular meshwork. Depending upon the specific treatment contemplated, pharmaceuticals may be utilized in conjunction with the trabecular stent enabling post-cataract healing processes.05-03-2012
20110137226ANTI-OBESITY DIVERTER STRUCTURE - The anti-obesity diverter structure includes a laminate structure having papilla-supplied and pylorus-supplied surfaces. The laminate structure is sized to fit longitudinally within a duodenum such that a transverse clearance is provided between the papilla-supplied surface and papilla of Vater. The laminate structure is secured within the duodenum to define papilla-supplied and pylorus-supplied lumens therein. The papilla-supplied lumen receives the digestive fluid from the papilla of Vater, and provides a conduit for the digestive fluid therein. The pylorus-supplied lumen receives the chyme from the pylorus and provides a conduit for the chyme therein. The laminate structure is impervious or semi-permeable to the chyme and digestive fluid.06-09-2011
20100125237IMPLANT FOR USE IN SURGERY FOR GLAUCOMA AND A METHOD - An implant for use in surgery for glaucoma of an eye having an oval plastic piece to which a tube is attached. The oval is wrapped as a taco enclosing the tube. The oval is placed via an incision in the conjunctiva to allow the device to be placed under the lateral or the medial rectus muscle. The tube is disposed in a sceral flap in the eye. A surgical method using the device is disclosed.05-20-2010
20090088678TRANSLUMENAL PERITONEAL ACCESS AND CATHETER THEREFOR - A working cannula is advanced through the urethra into the bladder. Gas is infused through the cannula into the bladder, pressurizing the bladder. A fenestrating shunt catheter is then advanced through the urethra into the bladder and against the wall of the bladder, fenestrating it. A distal segment of the shunt catheter is then advanced through the wall into the peritoneal space, while a more proximal segment of the shunt catheter remains in the bladder. Shunt holes are formed in both the distal segment and more proximal segment so that gas from the pressurized bladder flows through the shunt holes into the peritoneal space, insufflating the peritoneal space.04-02-2009
20100268149ANTIMICROBIAL GAS IMPREGNATING DEVICES AND METHODS - A nitric oxide gas-releasing conduit configured for surgical implantation through a patient's tympanic membrane. The nitric oxide gas-releasing conduit comprises a gas-permeable cured resin material configured for releasably sequestering therein gas. The gas-permeable cured resin material is charged with nitric oxide gas. The nitric oxide gas-releasing conduit may be optionally coated with an antimicrobial gas-releasing composition. The gas-releasing coating composition may be configured to release nitric oxide.10-21-2010
20090143712SELF-TREPHINING IMPLANT AND METHODS THEREOF FOR TREATMENT OF OCULAR DISORDERS - Implants and methods for treating ocular disorders are disclosed. One implant has a tubular member, with inlet and outlet ends, and a cutting member connected thereto. The tubular member is configured to extend through eye tissue such that the inlet and outlet ends reside respectively in an anterior chamber and a physiologic outflow pathway of the eye. Desirably, the cutting member is configured to make an incision in the eye tissue for receiving at least a portion of the tubular member. One method involves introducing an implant, with proximal and distal ends, into the anterior chamber and penetrating eye tissue using an implant distal portion. The implant is advanced from the anterior chamber into the penetrated eye tissue to locate the distal and proximal ends respectively in the physiologic outflow pathway and the anterior chamber. Aqueous humor is conducted between the proximal and distal ends.06-04-2009
20120296255DEVICE FOR PUNCTURING BODY AND INTRODUCING CATHETER - A device for puncturing body and introducing catheter includes a puncture needle, a guide wire, a peelable catheter sheath, and a puncture protector. The peelable catheter sheath includes an outer sheath and an inner sheath inserted into the outer sheath and having an expansible performance. The inner sheath has a hollow internal cavity, and the guide wire can pass through the hollow internal cavity. The puncture protector includes an inner core, a nut and a spring. The inner core has an inner core head, an inner core tail, and an inner core lumen. The nut has a nut lumen. The inner core is surrounded by the spring, one end of which abuts against the nut, and the other end of which is fastened to the inner core. The inner core tail lies within the nut lumen. The guide wire matches with the inner core lumen.11-22-2012
20110270149IMPLANTABLE ARTERIO-VENOUS SHUNT DEVICES AND METHODS FOR THEIR USE - A long-term implantable arterio-venous shunt device or creation of a fistula is provided that can be used as a therapeutic method for treating chronic obstructive pulmonary disease (COPD). The shunt device is implanted between an artery and a vein, preferably between a peripheral artery and the inferior vena cava. The shunt device and method of creating a fistula increases cardiac output and decreases the systemic vascular resistance and allows a blood flow rate through the shunt device of at least 5 ml/min after the implantation. Based on the effects of the method and device to the respiratory, cardiac and circulatory system, the method and device are beneficial as a therapy to patients with problems or conditions related to these systems.11-03-2011
20080249457IMPLANTABLE DRAINAGE DEVICE WITH PLANAR DUAL CURVED PORTION - In a first embodiment, implantable drainage devices with a curvilinear portion are provided, such as stents or drainage catheters formed as a tubular member having a curvilinear portion comprising one or more pairs of adjacent bends curved in opposite directions. The drainage devices house a drainage lumen that may extend through the curvilinear portion, which may be dimensioned to retain the drainage device within a body vessel and provide a desired fluid conductance through a tortuous portion of the drainage lumen within the curvilinear portion. The curvilinear portion may include two or more planar bends facing in opposite directions. The drainage device is preferably a biliary stent or drainage catheter constructed of thermoplastic material resilient enough to permit the bends of the curvilinear portion to straighten in response to placement of a guidewire through the drainage lumen, and to permit a portion of the tubular member to again form the plurality of bends when the guidewire is removed from the drainage lumen. In a second embodiment, methods of implanting the drainage devices within a body vessel, such as a biliary duct, are provided. For example, the drainage device may be a biliary stent implanted within the Papilla of Vater (e.g, within a biliary or pancreatic duct) without traversing the Sphincter of Oddi.10-09-2008
20120296254METHODS AND DEVICES FOR INTRAGASTRIC SUPPORT OF FUNCTIONAL OR PROSTHETIC GASTROINTESTINAL DEVICES - Disclosed herein are systems and methods for attaching or maintaining the position of a therapeutic or diagnostic device in a body lumen, such as the GI tract without necessarily requiring any penetrating attachments through any body walls. The system can include at least two elements: a proximal orientation element and a distal support element. The proximal orientation element can be configured to reside at least partially within the esophageal lumen and the distal support element can be configured to reside in the stomach, such as along the greater curve of the stomach.11-22-2012
20120296256ENDOVASCULAR CEREBROSPINAL FLUID SHUNT - An implantable shunt device for draining cerebrospinal fluid from a patient's subarachnoid space. The device includes a shunt having opposed first and second ends. A one-way valve is located at the first end of the shunt. A helical tip is disposed at the second end. The helical tip is constructed to penetrate a sinus wall of the patient. Upon implantation, a hollow passageway extends between the helical tip and one-way valve such that fluid can be drained through the helical tip and out through the valve. The endovascular cerebrospinal fluid shunt of the present invention can be placed into a patient percutaneously via a catheter inserted into the venous system of the body through a needle hole, without the need for open surgery and the skin incisions required with current shunt devices. The device also allows for more physiologic drainage of cerebrospinal fluid since the device is shunting cerebrospinal fluid into the same cerebral venous system that occurs naturally in normal people.11-22-2012
20090264808Biliary/Pancreatic Shunt Device and Method for Treatment of Metabolic and Other Diseases - Provided is a shunt device that promotes stimulation of secretion of intestinal L-cells and other enteroendocrine cell types. Enteroendocrine secretion is stimulated directly or indirectly by shunting bile and/or pancreatic secretion to segments of the gut more distal than would normally occur The shunt device may be a flexible catheter that is impervious to such secretions, with a proximal end draining the pancreatic/bile duct, and a distal end residing distally within the lumen of the small or large intestine. The shunt may be inserted with minimally invasive techniques, such as by endoscopy.10-22-2009
20080306428Lacrimal Drainage Device and Method - A lacrimal bypass drainage device (12-11-2008
20120143117LACRIMAL DRAINAGE MANOMETER AND METHOD OF USE - A lacrimal drainage manometer includes a syringe, a pressure sensor operably coupled to the syringe, a flow sensor operably coupled to the syringe, and a user feedback unit. The syringe includes a syringe body and a piston. The syringe body defines a fluid cavity in fluid communication with a cannula, which is configured for insertion into at least a portion of a lacrimal drainage system. The piston is for dispensing a fluid from the fluid cavity through the cannula. The user feedback unit is in electrical communication with each of the pressure sensor and the flow sensor. The user feedback unit is operably coupled to the syringe and configured to provide user feedback based on data from the pressure sensor and/or the flow sensor.06-07-2012
20090036819DRUG ELUTING OCULAR IMPLANT WITH ANCHOR AND METHODS THEREOF - Ocular implants, delivery devices and methods for treating ocular disorders are disclosed. One method involves inserting an implant on one side of an eye. The implant has an anchor on a distal end portion and an outlet opening that is disposed proximal of the anchor. The implant is advanced across the eye to the other side of the eye. The anchor is inserted into eye tissue on the other side of the eye. A therapeutic agent is eluted using the implant.02-05-2009
20110208109AUTORETROPERFUSION DEVICES AND SYSTEMS - Devices, systems, and methods for providing retroperfusion to at least one ischemic tissue in a minimally invasive manner are disclosed. At least some of the embodiments disclosed herein enable an anastomosis to be formed between a vein and an artery without the use of sutures and through a non-invasive procedure. In addition, various disclosed embodiments provide a cannula device comprising a Y-configuration for bifurcating arterial flow between an anastomosis and the underlying artery. The devices, systems and methods herein can further provide simultaneous autoretroperfusion therapy to more than one area of an ischemic tissue.08-25-2011
20090030363LINEARLY EXPANDABLE URETERAL STENT - A method includes placing a ureteral stent on an insertion tool. The ureteral stent includes an elongate member having a distal end coupled to a distal retention member. The elongate member includes a solid spring wire having a plurality of coils defining a lumen. A first portion of the insertion tool is disposed within the lumen, and the distal retention member, which has a nominally curved shape, is disposed about a second portion of the insertion tool such that the distal retention member is substantially linear. The insertion tool is inserted into the body of the patient and the ureteral stent is moved along the insertion tool such that at least a portion of the distal retention member is disposed within the kidney and at least a portion of the elongate member is disposed within the ureter of the patient. The insertion tool is removed from the body.01-29-2009
20120197176INTRAOCULAR IMPLANTS AND METHODS AND KITS THEREFOR - Devices, methods and kits are described for reducing intraocular pressure. The devices include a support that is implantable within Schlemm's canal and maintains the patency of the canal without substantially interfering with transmural fluid flow across the canal. The devices utilize the natural drainage process of the eye and can be implanted with minimal trauma to the eye. Kits include a support and an introducer for implanting the support within Schlemm's canal. Methods include implanting a support within Schlemm's canal, wherein the support is capable of maintaining the patency of the canal without substantial interference with transmural fluid flow across the canal.08-02-2012
20090088677EAR TUBES - The invention provides a flexible ear tube (04-02-2009
20090137942Device For Implantation of Retrograde Ventriculo-Sinus Shunt - A shunt system for implantation of retrograde ventriculo-sinus shunts to establish a water tight connection that drains excess cerebrospinal fluid from hydrocephalic brain ventricles and delivers it, against the direction of blood flow, in a dural sinus comprising a valveless shunting catheter and a styforator. Retrograde ventriculo-sinus shunts mimic natural drainage of cerebrospinal fluid; they utilize natural forces to regulate the intraventricular pressure and to maintain it more than the sinus pressure, to prevent regurgitation of blood in the shunting catheter as a result of changes in posture or intra-thoracic pressure, to maintain a steady flow of cerebrospinal fluid to the venous circulation at a rate equal to and dependent upon the rate of it's formation, to discourage stagnation and clotting of blood at the venous end of the connection and to prevent siphonage in the erect posture.05-28-2009
20100004580SHUNT DEVICE AND METHOD FOR TREATING OCULAR DISORDERS - Shunt devices and a method for continuously decompressing elevated intraocular pressure in eyes affected by glaucoma by diverting excess aqueous humor from the anterior chamber of the eye into Schlemm's canal where post-operative patency can be maintained with an indwelling shunt device which surgically connects the canal with the anterior chamber. The shunt devices provide uni- or bi-directional flow of aqueous humor into Schlemm's canal.01-07-2010
20090177138Shunt Device for Glaucoma Treatment - An improved indwelling shunt device for use in treating glaucoma is provided, comprising a flexible plate for placement on the eye, a tube for draining aqueous fluid from the anterior chamber of the eye, said tube having a proximal end and a distal end; and an adjustment element in moveable communication with the proximal region of said tube, adapted to allow modification of the length of the tube extending therefrom. An improved device for engaging the superior and lateral rectus muscles is also provided, comprising a handle; a first hook sized and shaped to engage a rectus muscle; and a second hook sized and shaped to engage a rectus muscle, wherein said second hook is moveable with respect to said first hook.07-09-2009
20110224597IMPLANT FOR INSERTING INTO THE SCHLEMM'S CANAL OF AN EYE - An implant for inserting into an exposed Schlemm's canal is proposed. The implant insertable into the lumen of Schlemm's canal includes an elongated tube which includes an axially extending continuous connecting part having several openings or recesses distanced from each other by web shaped ring members and connecting to the interior of the tube with and with arc shaped surfaces, such that in inserted condition the webs are bearing in supporting manner against the inner wall of the lumen of Schlemm's canal. The openings/recesses form a direct and permanently open connection between the trabecular tissue and the small channels of the channel system for natural trabecular drainage of the aqueous humor.09-15-2011
20110224596Tissue Penetrating Catheters Having Integral Imaging Transducers and Their Methods of Use - A catheter device that is useable to penetrate from a blood vessel in which the catheter device is positioned to a target location comprises a flexible catheter advanceable into the first blood vessel, a tissue penetrator lumen adapted to receive an operative tissue penetrator which is usable to penetrate from the blood vessel to the target location when properly aimed. Further said catheter including an imaging transducer fixedly mounted on or within the catheter body to provide an imaging signal from which an image of the target location can be obtained. The catheter device may include an imageable marker on the catheter to form on the image obtainable from the imaging signal a penetrator path indication that indicates the path that will be followed by the tissue penetrator when the tissue penetrator exits from the catheter. Alternatively, or addition thereto, the imaging transducer may comprise a plurality of imaging elements which are located so that the penetrator path indication can be obtained. A method of utilizing such a catheter device to bypass an arterial obstruction is also disclosed.09-15-2011
20090198172INTERVENTIONAL SHEATH WITH RETENTION FEATURES - A device for use in accessing and treating an artery comprises a sheath having a distal end adapted to be introduced into the artery, a proximal end, and a lumen extending between the distal and proximal ends. A retention feature is on the sheath, wherein the retention feature engages the wall of the artery to retain the sheath within the artery after the sheath has been introduced into the artery.08-06-2009
20110144559MEDICAL DRAINAGE DEVICES WITH CARBON-BASED STRUCTURES FOR INHIBITING GROWTH OF FIBROBLASTS - Drainage devices for draining a fluid from a patient during treatment of a medical condition body are disclosed. The drainage devices comprise a body defining at least one conduit through the body from a distal end of the body to a proximal end of the body. The body comprises at least one carbon-based structure configured to inhibit growth of fibroblasts in the conduit when the fluid flows through the conduit. Example embodiments of the drainage device may include an ophthalmic shunt, a hydrocephalus shunt, an artificial mesh, an arteriovenous shunt, a thoracic catheter, and a central venous access device.06-16-2011
20110144560Incisionless Gastric Bypass Method And Devices - A system and method for endoscopically forming an anastomosis between two naturally adjacent points in the digestive tract. The system and method utilizes elongate magnetic devices that, when connected across a tissue boundary, necrose tissue until an anastomosis forms and the devices are passed naturally. Despite the elongate shape of the devices, the resulting anastomosis is substantially round. As such, round anastomoses can be formed having increased diameters merely by increasing the lengths of the devices, obviating the need for wider endoscopes.06-16-2011
20120078158OCULAR IMPLANT WITH ANCHORING MECHANISM AND MULTIPLE OUTLETS - Devices and methods for treating ocular disorders are disclosed. One ocular implant, has a substantially straight, rigid, elongate body. The body has a self-trephinating distal portion that narrows toward a distal end, and at least one inlet that communicates with at least one inner lumen that communicates with a plurality of outlets. The lumen has a sufficient length to extend from an anterior chamber of an eye to a physiologic outflow pathway. An anchor member extends from the implant.03-29-2012
20090204053DEVICES AND METHODS FOR OPENING FLUID PASSAGEWAYS - Devices and procedures for assisting drainage of aqueous humor from the eye are provided. In accordance with some embodiments, an implant sized to fit within the Schlemm's Canal is provided. The implant has a plurality of penetrating members having an unextended position in which the penetrating members lie generally close to the longitudinal axis of the implant and an extended position in which the penetrating members are extended outward. In use, the implant is advanced around at least a substantial portion of the Schlemm's Canal with the penetrating members in the first unextended position. After the implant is positioned within the Schlemm's Canal, the penetrating members are caused to move from the first unextended position to the second extended position, wherein the penetrating members penetrate the wall of the Schlemm's Canal. This creates fluid passageways in the wall of the Schlemm's Canal. The implant can also serve to keep the Schlemm's Canal open. A delivery device is also provided for implanting an implant into the Schlemm's Canal.08-13-2009
20100152641INTERNAL SHUNT AND METHOD FOR TREATING GLAUCOMA - A surgical technique and device wherein an indwelling tube is placed in the eye of a patient having glaucoma. The tube diverts aqueous humor from the anterior chamber to the suprachoroidal space from which it is removed by blood flowing in the choroidal and uveal tissues. This decreases the intraocular pressure.06-17-2010
20100168644Glaucoma Treatment Device and Method - A device for treating glaucoma in an eye is described.07-01-2010
20100185137DEVICE FOR TREATMENT OF WATERING OF THE EYE - The present invention relates to a device (07-22-2010
20110060264DEVICE AND METHOD FOR VASCULAR ACCESS - Vascular access systems for performing hemodialysis are disclosed. The vascular access system contemplates a catheter section adapted for insertion into a vein and a graft section adapted for attachment to an artery. The catheter section may have metal or polymer wall reinforcements that allow the use of thin-walled, small outer diameter conduits for the vascular access system. One or more of the adhered, embedded or bonded conduit reinforcement structures may be removable without significant damage to the conduit sections to facilitate attachment of the sections, or to a connector between the sections. Various self-sealing materials are provided for use in the vascular access system, as well as temporary access sites and flow control/sensor systems.03-10-2011
20100191167GASTROINTESTINAL IMPLANT AND METHODS FOR USE - Methods and devices for modifying the location at which bodily fluids interact with nutrients in a gastrointestinal tract. The methods and devices utilize a conduit configured to divert bodily fluids from an entrance within a gastrointestinal tract to a location downstream from the entrance.07-29-2010
20090076436OCULAR IMPLANTS WITH DEPLOYABLE STRUCTURE - An implant has a tubular member with an inlet configured to receive fluid from an anterior chamber of an eye, an outlet configured to deliver fluid from the inlet to a physiological outflow pathway of the eye, and a lumen therebetween configured for substantially free flow of the fluid and which generally defines a flow axis. At the outlet of the tubular member is a distal deployable portion that has a compacted position and an expanded position. The deployable portion is configured to expand in the physiological outflow pathway of the eye and moves transversely when transitioning between the compacted and expanded positions about a pivot axis which is substantially perpendicular to the flow axis. 03-19-2009
20120035524EXPANDABLE OCULAR DEVICES - Disclosed herein are systems, devices and methods for treating an ocular disorder in an eye. The ocular device includes a proximal end, a distal end, and an internal lumen forming a flow pathway extending from the proximal end to the distal end; at least one inflow region that communicates with the flow pathway; and an expandable portion having a plurality of interconnected struts forming multiple openings in the device communicating with the flow pathway. The expandable portion has a first cross-sectional shape suitable for insertion into the eye that is generally cylindrical and a second cross-sectional shape that is larger than the first cross-sectional shape. The system also includes a delivery device for inserting the ocular device into an eye including a sheath configured to surround at least a portion of the ocular device; an applier configured to insert into the internal lumen of the ocular device; and an actuator.02-09-2012
20100222733Glaucoma Treatment Method - An ocular implant adapted to reside at least partially in a portion of Schlemm's canal of an eye. In some embodiments the implant has a body extending in a curved volume whose longitudinal axis forms an arc of a circle, and a plurality of open areas and strut areas formed in the body, the open areas extending over more than 50% of a surface defining the curved volume, the strut areas surrounding the open areas, the body having a diameter of between 0.005 inches and 0.04 inches. The invention also provides a method of treating glaucoma including the steps of supporting tissue forming Schlemm's canal in an eye with an implant extending at least partially in the canal along an axial length within the canal; and contacting with the implant less than 50% of the tissue forming the canal along the axial length.09-02-2010
20120245505INTRACAMERAL DEVICES FOR SUSTAINED DELIVERY - Described herein are intracameral drug and/or therapeutic bioactive agent delivery devices comprising a substantially cylindrical structure for at least partial placement into the anterior chamber of an eye The intracameral delivery devices have a sustained release material associated with at least a portion of the device and at least one drug and/or therapeutic bioactive agent associated with said sustained release material.09-27-2012
20080269662CONDUIT DEVICE AND SYSTEM FOR IMPLANTING A CONDUIT DEVICE IN A TISSUE WALL - Various embodiments of the present invention provide a conduit device including an attaching device configured for defining a helical pathway through a tissue wall and complementary ring in cooperation for securing the device within an aperture defined in the tissue wall. Some embodiments of the present invention further provide a system for implanting a conduit device in a tissue wall. More specifically, some embodiments provide a system including a coring device for defining an aperture in a tissue by removing and retaining a tissue core and securely implanting a conduit device therein so as to provide fluid communication between a first and second surface of the tissue wall via the conduit device.10-30-2008
20130131575SYSTEMS, DEVICES, AND METHODS INCLUDING INFECTION-FIGHTING AND MONITORING SHUNTS - Systems, devices, methods, and compositions are described for providing an actively controllable shunt configured to, for example, monitor, treat, or prevent an infection.05-23-2013
20110172585ANTI-OBESITY DUAL STENT - The anti-obesity dual stent includes a tubular outer structure within which is located a coaxial tubular inner structure. The outer structure is sized to fit within a duodenum in substantially coaxial relation therewith. The outer and inner structures communicate with the pylorus and papilla of Vater to provide conduits for the chyme and digestive fluid. Alternatively, the anti-obesity dual stent may include a tubular papilla-supplied structure which has a lateral orientation relative to a tubular pylorus-supplied structure. The papilla-supplied and pylorus-supplied structures each are sized to fit longitudinally within the duodenum. The pylorus-supplied and papilla-supplied structures communicate with the pylorus and papilla of Vater to provide conduits for the chyme and digestive fluid.07-14-2011
20110172584SYSTEMS AND METHODS FOR BARIATRIC THERAPY - The present invention provides bariatric therapy systems. One system includes a gastrointestinal implant device and a delivery mechanism therefor. The device can include a sleeve for placement into a small intestine and to minimize absorption of nutrients by its walls. An anchoring mechanism coupled to a proximal end of the sleeve and designed to be secured within the stomach can be provided. A passageway extending through the anchoring mechanism and the sleeve can also be provided, along which food can be directed from the stomach to the small intestine. The delivery mechanism can include a housing for accommodating the device, and a deploying balloon situated within the housing and which can be actuated to direct the sleeve of the device from within the housing to the site of implantation. Methods for providing bariatric therapy are also provided by the present invention.07-14-2011
20090036817IMPLANTABLE FLOW CONNECTOR - An implantable flow connector for fluidically coupling a source tissue-enclosed body space with a destination element, comprising: a conduit having a lumen terminating at an orifice at a first end of the conduit implantable in the source body space through an opening formed in a tissue wall of the source body space, and a second end of the conduit implantable in the destination element through an opening in a surface of the destination element; and a circumferential flange, radially extending from the conduit proximate the conduit first end, configured to be implanted in the source body space adjacent an opening in the tissue wall of the source body space such that the conduit extends through the opening, the flange comprising one or more circumferentially adjacent sections at least one of which has a rigidity that decreases in a radially-increasing direction.02-05-2009
20100331756Methods and Apparatus for Anchoring within the Gastrointestinal Tract - The present invention relates to an anchor configured for minimally-invasive implantation and sized to remain securely positioned within at least a portion of the gastrointestinal tract of an animal. The anchor includes a radial spring formed from an elongated resilient member shaped into an annular wave pattern about a central axis. The anchor defines a central lumen and provides an outward radial force, while allowing for substantial flexure about its perimeter. The anchor is generally removable, but can include fasteners, such as barbs, to further secure it to the surrounding anatomy. In some embodiments, the anchor includes a connector coupling a fixed portion to a removable portion. Further, the anchor can be used to secure a medical device within the body, such as a flexible sleeve within the intestine.12-30-2010
20110213292MINIMALLY INVASIVE GASTROINTESTINAL BYPASS - A solution is provided for modifying the location at which bodily fluids interact with nutrients in a gastrointestinal tract having a conduit with a first end and a second end. The first end is configured to divert bodily fluids from an entrance within a gastrointestinal tract to a location downstream from the entrance. The solution also provides for a means for attaching the second end to the entrance.09-01-2011
20110040230MINIMALLY INVASIVE GASTROINTESTINAL BYPASS - A solution is provided for modifying the location at which bodily fluids interact with nutrients in a gastrointestinal tract having a conduit with a first end and a second end. The first end is configured to divert bodily fluids from an entrance within a gastrointestinal tract to a location downstream from the entrance. The solution also provides for a means for attaching the second end to the entrance.02-17-2011
20110040232DUODENAL LINER DEVICE - Disclosed are tethered duodenal liner devices as well as methods of transcutaneously deploying and removing the tethered duodenal liner devices.02-17-2011
20110245752METHODS OF TREATMENT USING A BARIATRIC SLEEVE - Method and apparatus for limiting absorption of food products in specific parts of the digestive system is presented. A gastrointestinal implant device is anchored in the stomach and extends beyond the ligament of Treitz. All food exiting the stomach is funneled through the device. The gastrointestinal device includes an anchor for anchoring the device to the stomach and a flexible sleeve to limit absorption of nutrients in the duodenum. The anchor is collapsible for endoscopic delivery and removal.10-06-2011
20110087148OCULAR IMPLANT WITH STIFFNESS QUALITIES, METHODS OF IMPLANTATION AND SYSTEM - Described herein are devices and methods for treating eye conditions. Described is an ocular implant including an elongate member having an internal lumen forming a flow pathway, at least one inflow port communicating with the flow pathway, and at least one outflow port communicating with the flow pathway. The elongate member is adapted to be positioned in the eye such that at least one inflow port communicates with the anterior chamber, at least one outflow port communicates with the suprachoroidal space to provide a fluid pathway between the anterior chamber and the suprachoroidal space when the elongate member is implanted in the eye. The elongate member has a wall material imparting a stiffness to the elongate member. The stiffness is selected such that after implantation the elongate member deforms eye tissue surrounding the suprachoroidal space forming a tented volume.04-14-2011
20110087146STOMACH BYPASS FOR THE TREATMENT OF OBESITY - The present application provides devices and methods for inducing weight loss. In particular, the present application provides devices which are secured in the stomach or external to the stomach to reduce digestion and/or absorption of food in accordance with the methods of the invention04-14-2011
20100160847SYSTEMS, APPARATUSES, AND METHODS FOR CARDIOVASCULAR CONDUITS AND CONNECTORS - A cardiovascular conduit system may comprise a connector. The connector may comprise a proximal end adapted to attach to a cardiovascular organ. The proximal end may comprise a first plurality of expandable members, and each member in the first plurality of expandable members may be deployable from a delivery position to a deployed position. The first plurality of expandable members may be dimensioned to deploy inside the cardiovascular organ to secure the connector to the cardiovascular organ. The connector may comprise a distal end adapted to attach to a conduit and an opening extending through the connector. Connectors for cardiovascular conduit systems may also include expandable stents. Connectors may be rotateably secured to a conduit, and the conduit may be reinforced. Methods for forming and using cardiovascular conduit systems are also disclosed.06-24-2010
20110087147METHODS AND SYSTEMS FOR TREATMENT OF ACUTE ISCHEMIC STROKE - Methods and devices are disclosed that enable safe, rapid and relatively short and straight access to the cerebral arteries for the introduction of interventional devices to treat acute ischemic stroke. In addition, the disclosed methods and devices provide means to securely close the access site to the cerebral arteries to avoid the potentially devastating consequences of a transcervical hematoma.04-14-2011
20110087151OCULAR PRESSURE REGULATION - Disclosed are devices and methods of treating an ocular disorder including forming a self-sealing incision in a cornea into an anterior chamber of an eye; introducing through the incision a fluid drainage tube having a distal end, a proximal end and a longitudinal, internal lumen extending through the fluid drainage tube, wherein at least the proximal end passes through the anterior chamber; and implanting the distal end of the fluid drainage tube in fluid communication with the suprachoroidal space such that the proximal end of the fluid drainage tube remains in fluid communication with the anterior chamber.04-14-2011
20110087149OCULAR PRESSURE REGULATION - Disclosed are devices and methods of treating an ocular disorder including forming a self-sealing incision in a cornea into an anterior chamber of an eye; introducing through the incision a fluid drainage tube having a distal end, a proximal end and a longitudinal, internal lumen extending through the fluid drainage tube, wherein at least the proximal end passes through the anterior chamber; and implanting the distal end of the fluid drainage tube in fluid communication with the suprachoroidal space such that the proximal end of the fluid drainage tube remains in fluid communication with the anterior chamber.04-14-2011
20090326431TUBULAR VASCULAR TRANSPLANT - A tubular vascular transplant (12-31-2009
20090036818Shunt and Method Treatment of Glaucoma - This invention provides a shunt for implantation between the anterior chamber of the eye and the epithelial-lined space through the frontal sinus bone of a patient for the treatment of glaucoma. The shunt includes a tube having a length sufficient to span the distance between the anterior chamber of the eye and the epithelial-lined space of the patient, the tube having an open anterior chamber end and a closed epithelial-lined space end, and a seal device associated with the tube between the anterior chamber and epithelial-lined space ends, for sealing a hole in the frontal sinus bone, and for anchoring the tube against movement from the frontal sinus bone. The shunt also includes a fluid pressure openable valve in the tube, located at or near the epithelial-lined space sinus end, allowing for controlled flow of aqueous humor through the tube when implanted. The invention also extends to a method of treating glaucoma in a patient by surgically implanting the shunt between the anterior chamber of the eye and the frontal sinus.02-05-2009
20120245504DEVICES AND METHODS TO DELIVER, RETAIN AND REMOVE A SEPARATING DEVICE IN AN INTUSSUSCEPTED HOLLOW ORGAN - The present invention is an improved separating device for providing the malabsorptive component of a minimally invasive weight reduction system. This device may be a sleeve, liner, or tubular sheath that alters absorption of compositions through walls of hollow organs (stomach, intestines). The improvement involves better long-term retention through the ability of the device to engage with the interserosal fibrotic tissue formed in an intussusception. The separating device may be a distal extension of a retaining member that is directly engaged with and retained by intussuscepted tissue. Intussusception shrinks a hollow organ to provide a volume reducing restrictive component of a weight reduction system. Securing the separating device to an intussusception avoids retention problems of reference art devices as interserosal fibrosis helps secure the device. Also provided are an apparatus for retaining the device, a device and method for delivering the separating device, and a method for removing it.09-27-2012
20110098627C-Shaped Cross Section Tubular Ophthalmic Implant for Reduction of Intraocular Pressure in Glaucomatous Eyes and Method of Use - An implant may be used for implantation into tissue of a body. The implant includes an elongated conduit and a loop. The elongated conduit has an interior passageway for conducting fluid. The loop has an interior circumference with a fluid conducting channel formed therein. The channel is interconnected with the interior passageway for delivery of fluid between the channel and the interior passageway.04-28-2011
20100069820DEVICE, SYSTEM, KIT, AND METHOD FOR EPICARDIAL ACCESS - Described are equipment, a system, a kit and a method for the performance of a minimally-intensive body access, such as cardiac access. Epicardial Access Surgery (EAS) is disclosed. EAS does not need general anesthesia or extracorporeal circulation nor does it need a chest opening, which is very advantageous for various aspects. For instance an operation of a coronary artery bypass is created by creating a direct path of flow from one body artery into a coronary artery with the aid of catheter-based minimally-invasive EAS based bypass surgery. In addition, various medical devices are used, such as a special partially flexible needle, a special partially covered stent, and a special partially flexible port.03-18-2010
20110098629GLAUCOMA TREATMENT DEVICE - Methods and devices are adapted for implanting into the eye. An incision is formed in the cornea of the eye and a shunt is inserted through the incision into the anterior chamber of the eye. The shunt includes a fluid passageway. The shunt is passed along a pathway from the anterior chamber through the scleral spur of the eye into the suprachoroidal space and positioned in a first position such that a first portion of the fluid passageway communicates with the anterior chamber and a second portion of the fluid passageway communicates with the suprachoroidal space to provide a fluid passageway between the suprachoroidal space and the anterior chamber.04-28-2011
20110082407Combination Therapies for the Treatment of Obesity - Described are pharmaceutical compositions comprising topiramate, phentermine, and metformin, and at least one pharmaceutically acceptable carrier or excipient. Another aspect of the present invention relates to a method of treating a patient suffering from obesity or needing to lose weight, comprising the step of co-administering to said patient a therapeutically effective amount of topiramate, phentermine, and metformin. In certain embodiments, an aforementioned method is practiced in conjunction or tandem with a medical procedure or the use of a medical device or both.04-07-2011
20110071455METHOD AND APPARATUS FOR SUTURELESSLY CONNECTING A CONDUIT TO A HOLLOW ORGAN - An implantable connector for suturelessly connecting a conduit to a hollow organ, the implantable connector comprising:03-24-2011
20110071454Power Generator For Glaucoma Drainage Device - A glaucoma drainage device has a tube shunting the anterior chamber to a drainage location. A power generator has a rotor coupled to a micro-generator. The power generator is configured to generate energy from aqueous flowing through the tube. The force required to drive the rotor can be controlled to control the flow of aqueous through the tube. Alternatively, energy generated by the power generator is stored in a power source that powers an active valve, a pressure sensor, or telemetry.03-24-2011
20120302936EXTERNAL ANCHORING CONFIGURATIONS FOR MODULAR GASTROINTESTINAL PROSTHESES - Components may be used separately or in combination to create anchoring systems for intra-luminal implants for the treatment of metabolic disorders such as obesity and diabetes. Various systems include an external component adapted for deployment around a portion of the gastrointestinal tract (e.g., the duodenum) and an internal component adapted for implantation within the gastrointestinal tract. Various systems use anchoring means that are based on mechanical interference, elasticity, spring force, shape memory transformation, magnetic attraction, repulsion and/or levitation. Various embodiments rely on longitudinal anchoring of the implants with minimal force against tissue.11-29-2012
20120302935DEVICES AND METHODS FOR FORMING A FISTULA - Described here are devices, systems and methods for forming a fistula between two blood vessels. Generally, the systems may comprise a first catheter which may comprise a fistula-forming element. The fistula-forming element may comprise one or more electrodes, mechanical cutting elements, laser sources, or combinations thereof, and may be used to assist in fistula formation. In some instances, a system may comprise a second catheter, which may comprise a fistula-forming element. One or more of the catheters may comprise one or more markers, magnetic alignment elements, and/or one shape-changing elements.11-29-2012
20110040231TEMPORARY OSTOMY APPLIANCE - A temporary ostomy appliance is disclosed, including a catheter for extending through the abdominal wall into the intestine. The catheter may be a transcecal catheter for extending through the cecal valve into the ileum. A portion of a catheter that extends through the cecal valve is made collapsible when the catheter is empty. The collapsed portion expands to permit passage of effluent. A balloon carried on the catheter is preformed with a shape and size in order to permit inflation without elastic stretching of the balloon wall material. A filament is provided for permitting a portion of the catheter to be fastened to internal body tissue by surgical sutures or staples. In order to release the fastening without further surgery, the filament is withdrawn by pulling on a proximal portion outside the body.02-17-2011
20120203160IMPLANTS FOR REDUCING INTRAOCULAR PRESSURE - The present invention provides ocular implants adapted to reside in Schlemm's canal for reducing intraocular pressure of an eye and methods for using the same. In some embodiments the ocular implants comprise a thin rod adapted and configured to extend in a curved volume in Schlemm's canal. The thin rod comprises a plurality of wave-shaped segments such that a sufficient number and amount of wave-shaped segments extend to the inner wall of the trabecular meshwork and to the outer wall of Schlemm's canal thereby keeping Schlemm's canal open.08-09-2012
20120277656Natural Orifice Bariatric Procedure and Apparatus for Use Therewith - A method of performing a bariatric procedure through a natural body orifice is disclosed. The method comprises the step of providing a surgical instrument, comprising a handle portion, an elongated portion extending distally from the handle portion, and an end effector disposed adjacent a distal end of the elongated portion. The method also comprises the steps of inserting the surgical instrument through a natural body orifice of a patient such that the end effector is adjacent a portion of the patient's stomach, and using the surgical instrument to perform a surgical task.11-01-2012
20120123316INTRAOCULAR SHUNTS FOR PLACEMENT IN THE INTRA-TENON'S SPACE - The present invention generally relates to intraocular shunts, and in particular, to intraocular shunts configured to form a drainage pathway between the anterior chamber and the intra-Tenon's space.05-17-2012
20080306429UVEOSCLERAL DRAINAGE DEVICE - An ophthalmic shunt implantable in an eye has an elongate body and a conduit for conducting aqueous humor from an anterior chamber of the eye to the suprachoroidal space of the eye. The elongate body has a forward end, a spaced back end, and an insertion head that extends from the forward end. The insertion head defines a shearing edge suitable for cutting eye tissue engage thereby. The elongate body can define at least one slot that is configured for operative receipt of a surgical tool such as an obturator. In another aspect, at least a portion of the conduit can be configured for operative receipt of a surgical tool such as an obturator.12-11-2008
20110257580INTESTINAL SLEEVE - A gastrointestinal implant device is anchored in the duodenum and extends beyond the ligament of Treitz. All food exiting the stomach is funneled through the device. The gastrointestinal device includes an anchor for attaching the device to the duodenum and an unsupported flexible sleeve. The anchor can include a stent and/or a wave anchor and is collapsible for catheter-based delivery and removal.10-20-2011
20080214982FLUID MANAGEMENT FLOW IMPLANTS OF IMPROVED OCCLUSION RESISTANCE - This invention relates to achieving or improving uniform distribution of fluid flow in medical devices such as when combined with antibiotics impregnated in a catheter and/or with a drug-eluting catheter to further inhibit the catheter from becoming occluded by debris in the CSF or by bacterial biofilm formation or tissue proliferation in the catheter.09-04-2008
20110054381BILIARY SHUNTS, DELIVERY SYSTEMS, AND METHODS OF USING THE SAME - The application discloses devices, delivery tools, systems, and methods for treating biliary disease. Device comprise, for example, a component configured for deployment between a gallbladder and location within a gastrointestinal tract of a patient which has a proximal end and a distal end with a lumen extending therethrough. A method of deploying the device can be achieved by, for example, creating a duct or fistula between a gallbladder lumen and a portion of a gastrointestinal tract; and providing for drainage from the gallbladder to the gastrointestinal tract.03-03-2011
20110021968PANCREATIC EXOCRINE SECRETION DIVERSION APPARATUS AND METHOD - A method and apparatus for treating a patient's health condition by diverting pancreatic exocrine secretions include a flow diverter of material compatible with chronic residence within a small intestine of the patient. The flow diverter has a cover end and a discharge end. The flow diverter is sized to be placed within the small intestine with the discharge end placed distally from said cover end and with said flow diverter further sized so permit passage of chyme through the small intestine and past the flow diverter. The cover end is sized to cover a discharge papilla of the pancreatic duct. The diverter is adapted to divert at least a portion of pancreatic exocrine secretion from the papilla to the distal discharge end.01-27-2011
20100292629Systems, devices, and methods including infection-fighting and monitoring shunts - Systems, devices, methods, and compositions are described for providing an actively controllable shunt configured to, for example, monitor, treat, or prevent an infection.11-18-2010
20110118649METHOD AND DEVICE FOR THE TREATMENT OF GLAUCOMA - The invention relates to a method and a device for treatment of glaucoma, wherein by means of an elongated catheter provided with a distal portion and a proximal portion, a tube-shaped implant is inserted and released in a Schlemm's canal with two opposite openings exposed by an incision and a folded up scleral flap. In a first phase, the distal portion inserted into the Schlemm's canal through the first opening, while a fluid or gaseous medium is injected at the same time, and exited through the second opening, which is, in circumferential direction, oppositely located. The implant detachably disposed at the protruding distal portion and, in a second phase, inserted, in circumferential direction, into the expanded Schlemm's canal up to the first opening. Subsequently, the distal portion, which protrudes from the first opening, is detached from the implant and, together with the catheter, removed.05-19-2011
20110087150OCULAR PRESSURE REGULATION - Disclosed are devices and methods of treating an ocular disorder including forming a self-sealing incision in a cornea into an anterior chamber of an eye; introducing through the incision a fluid drainage tube having a distal end, a proximal end and a longitudinal, internal lumen extending through the fluid drainage tube, wherein at least the proximal end passes through the anterior chamber; and implanting the distal end of the fluid drainage tube in fluid communication with the suprachoroidal space such that the proximal end of the fluid drainage tube remains in fluid communication with the anterior chamber.04-14-2011
20100179468Side-by-side lacrimal intubation threader and method - A device to facilitate insertion or threading of a flexible silicone intubation stent into the lacrimal drainage system of a patient. The device has an oblong hollow semi-rigid probe having the flexible stent releasably secured to its blunted distal end. The probe and stent are oriented in a side-by-side configuration and inserted endwise through the punctal opening, down through the nasolacrimal duct and into the nasal cavity. The flexible stent is detached from the distal end of the probe, and the probe withdrawn, leaving the stent in place. The flexible stent can be temporarily secured to the distal end of the probe through a number of means. One preferred way is to friction fit a resilient distal aperture of the stent upon the distal end of the probe and occlude the probe's distal opening. The stent is detached by injecting a pressurized fluid through the channel of the probe thereby forcing the distal end of the stent to pop off. The proximal extremity of the stent is secured in the patient by an integrated or separate punctal anchor.07-15-2010
20100121248APPARATUS FOR REDUCING PRESSURE IN AN ORGAN - Methods, system and apparatus for relieving pressure in an organ such as, but not limited to, the eye are disclosed. The method includes implanting a bioabsorbable channel into the selected area of the organ using a delivery apparatus.05-13-2010
20100222732ANTI-CLOGGING VENTRICULAR CATHETER FOR CEREBROSPINAL FLUID DRAINAGE - A novel ventricular catheter designed to reduce CSF shunt obstruction is disclosed comprising a tip using a membrane without any opening and capable of filtering the CSF. When the CSF flows through the membrane, neither tissue (choroid plexus, blood cells, tumor cells, suctioned ependymal tissue) nor proteins can break through the membrane, making this ventricular catheter capable of preventing obstruction from tissue invasion but also preventing clogging from protein precipitation, coagulation or flocculation along the downstream shunt system.09-02-2010
20100069819Minimally invasive gastrointestinal bypass - A solution is provided for modifying the location at which bodily fluids interact with nutrients in a gastrointestinal tract having a conduit with a first end and a second end. The first end is configured to divert bodily fluids from an entrance within a gastrointestinal tract to a location downstream from the entrance. The solution also provides for a means for attaching the second end to the entrance.03-18-2010
20110144558FLUID FILLED IMPLANTS FOR TREATING MEDICAL CONDITIONS - An implant for treating medical disorders includes a first chamber having a flexible outer layer that surrounds a flexible inner layer, a second chamber in communication with the first chamber, and a fluid transfer assembly adapted for transferring fluid between the second chamber and the first chamber for selectively modifying the rigidity of the first chamber. The implant includes at least one restraining element in contact with the flexible outer and inner layers for at least partially restricting volume expansion of the first chamber as the fluid is transferred into the first chamber. The first chamber is adapted to become more rigid as the fluid is transferred into the first chamber and more flexible as the fluid is removed from the first chamber. The first chamber is implantable within the soft tissue of a patient such as a tongue, soft palate, pharyngeal wall, urinary tract, rectum, trachea, or stomach.06-16-2011
20110137227METHODS AND DEVICES FOR DELIVERING OR DELAYING LIPIDS WITHIN A DUODENUM - Devices are described that are adapted and configured for use within the duodenum of a mammal. One aspect of the device includes a spine having a proximal end and a distal end; an atraumatic feature positioned on at least one of the proximal end and the distal end of the spine; and a flow reduction element positioned along the spine and having a variable porosity along its length. In another aspect, there is a flow reduction device adapted and configured for use within the duodenum of a mammal having a spine having a length, a proximal end and a distal end; a first atraumatic feature positioned adjacent to the spine proximal end; a second atraumatic feature positioned adjacent to the spine distal end wherein the length of the spine is selected so that when the first atraumatic feature is in the stomach the second atraumatic feature is in the fourth portion of the duodenum; and a flow reduction element having a proximal end, a distal end, an interior portion, an exterior portion and a variable porosity between the proximal end and the distal end. Additionally or alternatively, some or all of the components of the device may be formed from or coated with a lipid-philic material. There is also provided a method for adjusting the passage of ingesta through the duodenum of a mammal. The method includes placing the distal end of a flow reduction device in the duodenum of a mammal; placing the proximal end of the flow reduction device in a stomach of the mammal; expanding within the duodenum of the mammal a variable porosity flow reduction element supported by the flow reduction device; and directing at least a portion of the flow of ingesta through the duodenum through the proximal end of the variable porosity flow reduction element and into an interior portion of the variable porosity flow reduction element.06-09-2011
20100030127DUCT STENT FOR CARRYING MINIATURE RADIOACTIVE PARTICLE SOURCES - A duct stent being capable of carrying the subminiature radioactive particle source is mainly used for the inside radiation therapy of metaphase or terminal pancreatic cancer and bile duct cancer, and has drainage function. The duct stent consists of a tubular drainage tube (02-04-2010
20100030126MONOCANALICULONASAL AND/OR MONOCANALICULAR INTUBATION ASSEMBLY, MAINLY FOR NASOLACHRYMAL IMPERFORATION - Monocanaliculonasal and/or monocanalicular intubation assembly mainly intended for nasolachrymal imperforation, comprising a mandrel (02-04-2010
20120150096IMPLANTABLE OR INSERTABLE MEDICAL DEVICES FOR CONTROLLED DRUG DELIVERY - Implantable or insertable medical devices are provided, which comprises: (a) a biocompatible polymer; and (b) at least one therapeutic agent selected from an anti-inflammatory agent, an analgesic agent, an anesthetic agent, and an antispasmodic agent. The medical devices are adapted for implantation or insertion at a site associated with pain or discomfort upon implantation or insertion. In many embodiments, the therapeutic will be selected from at least one of (i) ketorolac and pharmaceutically acceptable salts thereof (e.g., ketorolac tromethamine) and (ii) 4-diethylamino-2-butynylphenylcyclohexyl glycolate and pharmaceutically acceptable salts thereof (e.g., oxybutynin chloride). Also provided are uses for the implantable or insertable medical devices, which uses comprise reducing pain or discomfort accompanying the implantation or insertion of such devices. Further uses may comprise reducing microbial buildup along the device. Methods for manufacturing implantable or insertable medical devices are also provided.06-14-2012
20120150095ANTIMICROBIAL MATERIAL AND METHOD FOR MAKING THE SAME - This invention provides a modified catheter/indwelling device biomaterial that provides both immediate, and long-term microbiocidal effects on otherwise antibiotic-resistant strains of microorganisms. The material, which exhibits good mechanical performance characteristics for medical devices, is composed of a hydrophobic polyurethane (PU), a hydrophilic polyethylene vinyl acetate (PEVA) as an option, a soluble silver salt and a sparsely-soluble silver salt. The hydrophobic polyurethane provides the good physical properties, the PEVA the hydrophilicity necessary to allow some water ingress into the catheter, the soluble silver salt for an immediate burst effect, and the sparsely-soluble silver salt for sustained-release over many months postimplantation. Alternatively, the sparsely soluble silver salt can be silver iodate and is combined with silver sulfadiazine. Chlorhexidine can also be included in the material.06-14-2012
20110218476APPARATUS AND METHOD FOR GASTRIC BYPASS SURGERY - A medical treatment device includes an elongate member having an internal volume, a proximal end, and a distal end, the internal volume extending from the proximal end to the distal end. The medical treatment device further includes a first coupler and a second coupler, the first coupler and the second coupler coupled to the internal volume of the elongate member; a first joining member and a second joining member, the first joining member coupled to the first coupler and the second joining member coupled to the second coupler. The first joining member is configured to attach to a first biological matter location, and the second joining member is configured to attach to a second biological matter location, the second location being distal to the first location. The second coupler is configured for manipulation to align relative the first coupler such that the second biological matter location relocates adjacent the first biological matter location. The first joining member and the second joining member are configured to join the first biological matter location to the second biological matter location.09-08-2011
20120150093SYNOVIAL SHUNTS - Shunt for joint repair, creates a passageway between interior and exterior of a joint capsule, the shunt comprising a body of biocompatible material, which is substantially hollow; a proximal and distal aperture flanking said shunt body; at least a first and second extension of shunt body, first extension is located proximal to proximal aperture and second extension is located proximal to distal aperture, first and second extensions fasten or adjoin said shunt body, such that said shunt is substantially immobilized at a location of placement of said shunt; proximal aperture of shunt body is positioned proximal to an interior of joint capsule and shunt body spans at least a distance equal to that of synovial membrane, joint capsule or a combination thereof and distal aperture is located substantially outside of at least synovial membrane; the ratio between shunt body diameter and shunt body length is greater than 0.5.06-14-2012
20110306915Glaucoma Treatment Device - Methods and devices are adapted for implanting into the eye. An incision is formed in the cornea of the eye and a shunt is inserted through the incision into the anterior chamber of the eye. The shunt includes a fluid passageway. The shunt is passed along a pathway from the anterior chamber through the scleral spur of the eye into the suprachoroidal space and positioned in a first position such that a first portion of the fluid passageway communicates with the anterior chamber and a second portion of the fluid passageway communicates with the suprachoroidal space to provide a fluid passageway between the suprachoroidal space and the anterior chamber.12-15-2011
20110098628Internal and external disc shunts alleviate back pain - The intervertebral disc is avascular. Nutrients and waste are diffused through adjacent vertebral bodies into the disc. As we age, calcified layers form between the disc and vertebral bodies, blocking diffusion of nutrients, oxygen and pH buffer in blood. Under anaerobic conditions, lactic acid is produced, irritating nerve endings and causing nonspecific pain. In addition, the disc begins to starve and flatten. The weight shifts abnormally from disc to the facet joints causing strain and back pain.04-28-2011
20120209164Methods of replacing a gastrointestinal bypass sleeve for therapy adjustment - Methods are disclosed for replaceable attachment of an endoluminal gastrointestinal device, such as an artificial stoma device, a gastrointestinal bypass sleeve device or an attachment cuff, within a patient's digestive tract for treatment of obesity.08-16-2012
20120310137EYE SHUNT WITH POROUS STRUCTURE - Disclosed are devices and methods for treatment of eye disease such as glaucoma. An implant is placed in the eye wherein the implant provides a fluid pathway for the flow or drainage of aqueous humor from the anterior chamber to the supraciliary or the suprachoroidal space, or to any space in the eye where drainage to that location will lower the intraocular pressure. The implant may include an elongate compressible structure and may be implanted in the eye using a delivery system that folds and or compresses the implant to provide a smaller cross-sectional area to allow a more minimally-invasive procedure. The compressibility of the implant is provided by a porous structure that may be collapsed by compression and delivered through a tube-shaped introducer.12-06-2012
20120310136SELECTIVE ULTRAFILTRATION MEMBRANES FOR RENAL REPLACEMENT THERAPIES - A system and method provide improved ultrafiltration of charged/uncharged solutes in a fluid, especially a body fluid. The improvement is achieved through imposed electric field and/or surface charge patterning to a permeable membrane. In many of the embodiments, at least one selected material is used as an additive on a permeate side of the permeable membrane to reduce the sieving coefficient of the membrane with regard to a solute present in the fluid.12-06-2012
20120010555Cannula Implant Device for Use in Salivary Gland Ducts - A cannula for placement within a salivary gland duct having a first end adjacent an oral cavity and a second end adjacent a salivary gland is provided. The cannula includes an elongate body having a lumen and a first and a second plate offset from a proximal end of the elongate body. The first plate is located on one side of the elongate body and the second plate is correspondingly located on the other side of the elongate body and adjacent the first plate. The first plate has a first hole that is operable to suture the first plate to a location adjacent the first end of the salivary duct adjacent the oral cavity, whereby upon placement of the cannula within the salivary gland duct, saliva flows through the elongate body's lumen from the salivary gland to the oral cavity.01-12-2012
20120116285DEVICES FOR TREATING OBESITY AND METHODS OF USING THOSE DEVICES - Described here are devices for treating obesity. The devices are situated in the stomach and duodenum and maintain separation of the chyme stream leaving the stomach from the stream containing bile and pancreatic fluids exiting the Ampulla of Vater until well down into the small intestine. The devices, however, permit other digestive fluids to enter the chyme stream and hormones to enter the blood stream.05-10-2012
20110166494PROSTHESIS COMPRISING KNITTED MATERIAL LAYERS AND METHOD OF MANUFACTURING BY ULTRASONIC WELDING - The present invention relates to a prosthesis comprising at least two pieces of knitted fabric and to the method of manufacturing it using a sonotrode to perform ultrasonic welding. The prosthesis comprises at least one first piece of knitted fabric and at least one second piece of knitted fabric, which are welded together by means of a plurality of welds situated in a joining region in which at least a portion of the said first and second pieces of knitted fabric are superposed, the said first and second pieces of knitted fabric each comprising a group of yarns extending respectively in first and second directions A and B, characterized in that the said directions A and B are substantially aligned with one another in the said joining region, and each said weld in the joining region is of elongate shape with its longitudinal axis being aligned with the said directions A and B.07-07-2011
20120016287SATIATION DEVICES AND METHODS - A device for inducing weight loss in a patient includes a tubular prosthesis self-expandable from a collapsed position in which the prosthesis has a first diameter to an expanded position in which the prosthesis has a second, larger, diameter. In a method for inducing weight loss, the prosthesis is placed in the collapsed position and inserted into a stomach of a patient. The prosthesis is allowed to self-expand from the collapsed position to the expanded position and into contact with the walls of the stomach, where it induces feelings of satiety and/or inhibits modulation of satiety-controlling factors such as Ghrelin.01-19-2012
20120016286OCULAR IMPLANT WITH STIFFNESS QUALITIES, METHODS OF IMPLANTATION AND SYSTEM - Described herein are devices and methods for treating eye conditions. Described is an ocular implant including an elongate member having an internal lumen forming a flow pathway, at least one inflow port communicating with the flow pathway, and at least one outflow port communicating with the flow pathway. The elongate member is adapted to be positioned in the eye such that at least one inflow port communicates with the anterior chamber, at least one outflow port communicates with the suprachoroidal space to provide a fluid pathway between the anterior chamber and the suprachoroidal space when the elongate member is implanted in the eye. The elongate member has a wall material imparting a stiffness to the elongate member. The stiffness is selected such that after implantation the elongate member deforms eye tissue surrounding the suprachoroidal space forming a tented volume.01-19-2012
20120116284Treatment of the chronic renal disease by two-stage transplantations of a patient's kidney - The invention proposes a novel method of treatment of patients with chronic kidney disease (CKD). The method includes two stage transplantations of a patient's kidney: first, one of kidneys of the patient with CKD is transplanted into a young healthy animal recipient (preferably a pig), whereas a kidney of a living person or cadaver or an animal recipient is temporarily transplanted into the body of the patient. Homeostatic factors of the animal recipient will cause the transplanted kidney recovery. In the second stage, the recovered kidney is autotransplantated back to the patient. Up to this time both the animal recipient and the patient are treated by immunosuppressive drugs.05-10-2012
20130012862METHODS AND APPARATUS FOR ANCHORING WITHIN THE GASTROINTESTINAL TRACT - The present invention relates to an anchor configured for minimally-invasive implantation and sized to remain securely positioned within at least a portion of the gastrointestinal tract of an animal. The anchor includes a radial spring formed from an elongated resilient member shaped into an annular wave pattern about a central axis. The anchor defines a central lumen and provides an outward radial force, while allowing for substantial flexure about its perimeter. The anchor is generally removable, but can include fasteners, such as barbs, to further secure it to the surrounding anatomy. In some embodiments, the anchor includes a connector coupling a fixed portion to a removable portion. Further, the anchor can be used to secure a medical device within the body, such as a flexible sleeve within the intestine.01-10-2013
20120022424DEVICE FOR PLACING CIRCUMFERENTIAL IMPLANT IN SCHLEMM'S CANAL - A device is provided to enable placing an implant within the full circumference of Schlemm's canal of an eye. The device comprises a flexible elongated solid element with a proximal end and a distal tip that transmits light such as one or more strands of a fiber optic. The device is characterized by selected mechanical characteristics to allow advancement within Schlemm's canal. The fiber optic element transmits light from a proximal connector to the distal tip to provide a lighted tip that may be viewed transclerally when the device is advanced along Schlemm's canal.01-26-2012
20120022428BYPASS VASCULAR GRAFT - A vascular connector configured to bypass an occluded vessel comprises a primary graft stem and a venous outflow stem. In general, the primary graft stem accepts a blood flow from an occluded vessel to bypass the occlusion. The venous outflow stem may extend from a wall of the primary graft stem and divert a portion of the blood flow to a native vein or other vessel of the vascular system. This configuration is beneficial in ensuring adequate blood flow at the vascular connector to inhibit the formation of clots and to extend the patency of the vascular connector.01-26-2012
20120022430SATIATION DEVICES AND METHODS - A device for inducing weight loss in a patient includes a tubular prosthesis self-expandable from a collapsed position in which the prosthesis has a first diameter to an expanded position in which the prosthesis has a second, larger, diameter. In a method for inducing weight loss, the prosthesis is placed in the collapsed position and inserted into a stomach of a patient. The prosthesis is allowed to self-expand from the collapsed position to the expanded position and into contact with the walls of the stomach, where it induces feelings of satiety and/or inhibits modulation of satiety-controlling factors such as Ghrelin.01-26-2012
20120022429OCULAR IMPLANT WITH STIFFNESS QUALITIES, METHODS OF IMPLANTATION AND SYSTEM - Described herein are devices and methods for treating eye conditions. Described is an ocular implant including an elongate member having an internal lumen forming a flow pathway, at least one inflow port communicating with the flow pathway, and at least one outflow port communicating with the flow pathway. The elongate member is adapted to be positioned in the eye such that at least one inflow port communicates with the anterior chamber, at least one outflow port communicates with the suprachoroidal space to provide a fluid pathway between the anterior chamber and the suprachoroidal space when the elongate member is implanted in the eye. The elongate member has a wall material imparting a stiffness to the elongate member. The stiffness is selected such that after implantation the elongate member deforms eye tissue surrounding the suprachoroidal space forming a tented volume.01-26-2012
20120022427METHOD FOR INCREASING BLOOD FLOW IN OR ABOUT A CARDIAC OR OTHER VASCULAR OR PROSTHETIC STRUCTURE TO PREVENT THROMBOSIS - A method is provided for increasing blood flow in or about a cardiac structure to prevent thrombosis. One step of the method includes providing an implantable sprayer having an elongated tubular body with proximal and distal end portions. The distal end portion includes at least one opening and an anchoring mechanism. The distal end portion of the implantable sprayer is inserted into a cardiac chamber that includes the cardiac structure. The anchoring mechanism is then deployed so that the distal end portion of the implantable sprayer is secured in or about the cardiac structure. Next, the proximal end portion is anastomosed with an artery so that blood flows through the elongated tubular body of the implantable sprayer and is sprayed out of the at least one opening to continuously circulate blood in or about the cardiac structure.01-26-2012
20110021969PROSTHETIC DEVICE FOR CREATING A VASCULAR BYPASS, WITHOUT CLAMPING, FROM A BLOOD VESSEL - Prosthetic device for creating a vascular bypass from an arterial vessel, in particular from the aorta, which can have substantial collateral branches, characterized in that the device includes one or more prosthetic tubes of which one of the ends is joined to a flexible fixing collar with an outer face and an inner face which is configured to be applied to the outer wall of the arterial vessel. The collar has one or more orifices arranged in a central or orifice zone, and which communicate with the prosthetic tube or tubes. The collar has a connection zone arranged around the orifice zone at a distance from the edge of the orifice or orifices, and which is configured to be fixed to the outer wall of an arterial vessel. The inner face of this connection zone having at least one feature for creating an annular sealing zone around the orifice zone.01-27-2011
20120065570Disc shunt delivery with stepped needle - A solid stepped needle delivers a disc shunt bridging between muscle and a degenerated disc, drawing blood plasma from muscle into the degenerated disc to alleviate back pain and regenerate the disc. The device further includes pull lines attached to the ends of the disc shunt for withdrawing and repositioning the stepped needle during shunt delivery.03-15-2012
20110092878OCULAR IMPLANT DELIVERY SYSTEM AND METHODS THEREOF - Systems and methods for treating ocular disorders are disclosed. One system has a delivery instrument, with a non-linear axis, configured to be inserted into an anterior chamber of an eye and moved to a location proximate a physiologic outflow pathway of the eye. The delivery instrument carries an implant that has a distal end sized for insertion into tissue such that aqueous humor drains from the anterior chamber to the physiologic outflow pathway. One method involves inserting a non-linear portion of a delivery device into the anterior chamber to position an implant within the eye. Another method involves using a delivery device with a curved distal portion to implant an implant at a location communicating with the physiologic outflow pathway. The delivery can be through a corneal incision and the implant can comprise a drug.04-21-2011
20110092877DEVICE AND METHOD FOR ESTABLISHING AN ARTIFICIAL ARTERIO-VENOUS FISTULA - A shunt rivet for implantation in the aorta and inferior vena cava to treat chronic obstructive pulmonary disease, and a method of treating chronic obstructive pulmonary disease.04-21-2011
20100121249METHODS FOR REDUCING PRESSURE IN AN ORGAN - Methods, system and apparatus for relieving pressure in an organ such as, but not limited to, the eye are disclosed. The method includes implanting a bioabsorbable channel into the selected area of the organ using a delivery apparatus.05-13-2010
20120071809OCULAR IMPLANT SYSTEMS - Implants and methods for treating ocular disorders are disclosed. One implant has a tubular member, with inlet and outlet ends, and a cutting member connected thereto. The tubular member is configured to extend through eye tissue such that the inlet and outlet ends reside respectively in an anterior chamber and a physiologic outflow pathway of the eye. Desirably, the cutting member is configured to make an incision in the eye tissue for receiving at least a portion of the tubular member. One method involves introducing an implant, with proximal and distal ends, into the anterior chamber and penetrating eye tissue using an implant distal portion. The implant is advanced from the anterior chamber into the penetrated eye tissue to locate the distal and proximal ends respectively in the physiologic outflow pathway and the anterior chamber. Aqueous humor is conducted between the proximal and distal ends.03-22-2012
20110105990ZONAL DRUG DELIVERY DEVICE AND METHOD - Disclosed herein are ocular implants for treating an eye and methods of implantation including an elongate member having a proximal end with at least one inflow port, a distal end with at least one outflow port, and a longitudinal, internal lumen extending through the elongate member. The distal end of the elongate member is in fluid communication with the suprachoroidal space such that the proximal end of the elongate member remains in fluid communication with the anterior chamber when the elongate member is implanted in the eye. At least one polymeric film surrounds at least a portion of the elongate member, the film comprising a first drug delivery zone embedded with a first drug, wherein the first drug diffuses from the polymeric film over time into the eye at a first anatomical location.05-05-2011
20110105989In vivo punctal anchoring method for lacrimal stents - A device and method for performing stenting and intubation of the nasolacrimal system to treat for stenosis or obstruction includes a semi-rigid tubular guide sleeve through which a flexible tubular stent, having an oversized length, is inserted from a punctal opening into the nasal cavity. The guide sleeve is removed and a resilient, radially expandable punctal anchor is placed through the punctal opening, to contact the stent and hold it in place. An introducer device having a hollow tubular core and a coaxially mounted, axially translatable outer sheath is provided to facilitate placement of the anchor. The anchor is stretched over the distal end of the core and the stent threaded into the central lumen of the core. Once the anchor is in place, the sheath is translated to push the anchor off the distal end. Excess stent at its proximal end is then trimmed off.05-05-2011
20110105988Treating back pain by re-establishing the exchange of nutrient & waste - The intervertebral disc is avascular. With aging, endplates become occluded by calcified layers, and diffusion of nutrients and oxygen into the disc diminishes. The disc degenerates, and pain ensues. Conduits are delivered and deployed into the intervertebral disc to re-establish the exchange of nutrients and waste between the disc and bodily circulation to stop or reverse disc degeneration and relieve pain.05-05-2011
20110105987SYSTEM AND METHOD FOR TREATING AN OCULAR DISORDER - Surgical methods and related medical devices for treating ocular disorders are disclosed. Some methods relate to delivering an implant within an eye, and involve providing an elongate guide device, such as, a flexible guide member or a guide wire. A distal end of the guide device can be advanced into an anterior chamber of an eye, or through at least a portion of a site of resistance along a physiologic outflow pathway of the eye, or from an anterior chamber of the eye to a location proximate a physiologic outflow pathway of the eye. The implant is advanced along the guide device toward the guide device distal end, and is positioned to conduct aqueous humor between the anterior chamber and the physiologic outflow pathway.05-05-2011
20110105986UVEOSCLERAL DRAINAGE DEVICE - An ophthalmic shunt implantable in an eye having an elongate body and a branched conduit for conducting aqueous humor from an anterior chamber of the eye to the suprachoroidal space of the eye and the subconjunctival space, and a plate extending from an upper surface of the elongate body.05-05-2011
20110105985Treatment For Metabolic Disorders By Diverting Bile To the Circulatory System - The present invention generally provides for a method for diverting a portion of the bilopancreatic secretions of a patient to the circulatory system. The method involves placing a proximal end catheter adjacent the sphincter of oddi and diverting bilopancreatic secretions into the catheter. The method further involves placing a distal end of the catheter within the lumen of the circulatory system of a patient.05-05-2011
20080262406SECUREMENT DEVICE FOR SHUNT CATHETER AND IMPLANTATION METHOD THEREFOR - The invention relates to implantable systems for securing shunt catheters. The implantable system and device functions to maintain shunt patency and thus, shunt catheter malfunction due to obstruction is prevented10-23-2008
20120123315INTRAOCULAR SHUNTS - The present invention generally relates to different types of intraocular shunts.05-17-2012
20120150094METHOD AND DEVICE FOR USE IN ENDOSCOPIC ORGAN PROCEDURES - Methods and devices for use in tissue approximation and fixation are described herein. The present invention provides, in part, methods and devices for acquiring tissue folds in a circumferential configuration within a hollow body organ, e.g., a stomach, positioning the tissue folds for affixing within a fixation zone of the stomach, preferably to create a pouch or partition below the esophagus, and fastening the tissue folds such that a tissue ring, or stomas, forms excluding the pouch from the greater stomach cavity. The present invention further provides for a liner or bypass conduit which is affixed at a proximal end either to the tissue ring or through some other fastening mechanism. The distal end of the conduit is left either unanchored or anchored within the intestinal tract. This bypass conduit also includes a fluid bypass conduit which allows the stomach and a portion of the intestinal tract to communicate.06-14-2012
20120150092GUIDED PERCUTANEOUS BYPASS - The invention includes methods and apparatus to deploy a blood vessel conduit via a catheter-based, percutaneous approach. In particular, a prosthetic blood conduit can be introduced around or through an arterial obstruction without requiring open bypass surgery. The technology includes coupling devices for docking the tips of two catheters, one situated inside a blood vessel, the other situated outside the blood vessel wall.06-14-2012
20120165721SYSTEMS FOR DEPLOYING INTRAOCULAR SHUNTS - The present invention generally relates to systems for deploying intraocular shunts without the use of an optical apparatus that contacts an eye, such as a goniolens. In certain embodiments, systems of the invention include a locking mechanism, and a device configured to hold and deploy an intraocular shunt, in which a distal portion of the device is movable within a proximal portion of the device and the distal portion of the device is configured to mate with the locking mechanism to prevent movement of the distal portion when the locking mechanism is engaged.06-28-2012
20120123317METHODS FOR IMPLANATION OF GLAUCOMA SHUNTS - The present invention generally relates to the reduction of intraocular pressure, and in particular, to improved methods for implanting an intraocular shunt in the eye to treat glaucoma. The methods provide for implantation of an intraocular shunt while minimizing the risk of severe eye trauma due to the interaction between the deployment device and the surrounding eye tissue.05-17-2012
20090131848METHOD FOR IMPLANTING A TRANSCORNEAL IMPLANT THROUGH A PARACENTESIS T-INCISION, AND TRANSCORNEAL IMPLANT SO IMPLANTED - A method for implanting a transcorneal implant having a cap, a foot, and a body connecting the cap and the foot, the body having a lesser circumference than either the cap or the foot, the method including the operations: creating a first corneal incision to create a tunnel, such that the a far end of the first incision enters the anterior chamber; creating a second corneal incision opening a roof of the tunnel to an end point past the far end of the first incision and creating flaps; guiding the implant to the end point, so that the foot of the implant is under the flaps; rotating the implant until the foot is entirely within the anterior chamber; and rotating the implant back to a neutral position, such that a portion of the foot is beneath a floor of the tunnel.05-21-2009
20120172782METHODS FOR BILIARY DIVERSION - Methods are provided for biliary diversion. In one embodiment, a tubular member can be implanted within a patient by positioning a proximal end of the tubular member in the patient's gall bladder, positioning a distal end of the tubular member in the patient's intestine, and positioning a length of the tubular member extending between the proximal and ends thereof within the patient's stomach. Bile can therefore be allowed to pass from the gall bladder into the tubular member's proximal end, flow through the tubular member, and exit through the tubular member's distal end to enter the patient's gastrointestinal tract at the intestine.07-05-2012
20120232459DEVICES AND METHODS FOR ENDOLUMENAL GASTROINTESTINAL BYPASS - The present invention provides devices and methods for attachment of an endolumenal gastrointestinal device, such as an artificial stoma device, a gastrointestinal bypass sleeve or other therapeutic or diagnostic device, within a patient's digestive tract. In one application of the invention, an endolumenal bypass sleeve is removably attached in the vicinity of the gastroesophageal junction to treat obesity and/or its comorbidities, such as diabetes. The bypass sleeve may be at least partially deployed by eversion.09-13-2012
20120165720INTRAOCULAR SHUNTS - The present invention generally relates to different types of intraocular shunts.06-28-2012
20120130300Therapeutic Methods Using Controlled Delivery Devices Having Zero Order Kinetics - An injectable or implantable medical device having orifice(s) on the surface that release an active agent with zero-order release kinetics is described herein. The device is a hollow matrix of any size or shape, which can be made from both metal and non-metal surfaces. The device comprises of a reservoir capable of releasing at least one therapeutic, diagnostic, or prophylactic agent via the orifices to the desired anatomical site. The developed device, due to its composite structure, has the ability to combine several release mechanisms, leading to zero-order release kinetics for most of the time. The composition provides zero-order kinetics, in part, because the diffusion rate of the drug from the device is slow which enables sink conditions. Hence, no back transfer or build up of drug occurs at anytime. Polymers are not required for controlled release.05-24-2012
20120165722DEVICES AND METHODS FOR IMPLANTING A SHUNT IN THE SUPRACHOROIDAL SPACE - The invention generally relates to devices and methods for implanting a shunt in the suprachoroidal space of an eye. In certain aspects, devices of the invention include a housing, a deployment mechanism at least partially disposed within the housing, and a flexible hollow shaft coupled to the deployment mechanism, in which the shaft holds an intraocular shunt, and is configured to self-guide the shunt along a scleral spur of an eye as the shunt is deployed from the shaft. Such a device may be inserted into an eye and used to deploy a shunt within the eye such that a proximal portion of the shunt receives fluid from an anterior chamber of an eye and a distal portion of the shunt directs the fluid to the suprachoroidal space.06-28-2012
20120215152BARIATRIC SLEEVE - Method and apparatus for limiting absorption of food products in specific parts of the digestive system is presented. A gastrointestinal implant device is anchored in the stomach and extends beyond the ligament of Treitz. All food exiting the stomach is funneled through the device. The gastrointestinal device includes an anchor for anchoring the device to the stomach and a flexible sleeve. When implanted within the intestine, the sleeve can limit the absorption of nutrients, delay the mixing of chyme with digestive enzymes, altering hormonal triggers, providing negative feedback, and combinations thereof. The anchor is collapsible for endoscopic delivery and removal.08-23-2012
20120215153TUBE DEVICE FOR INSERTION INTO LACRIMAL PASSAGE - A tube device for insertion into a lacrimal passage, optimized according to the structure of a lacrimal passage and capable of being operated without impairing the functional effect of a lacrimal passage endoscope. A tube device for insertion into a lacrimal passage comprises a pair of tubes to be placed in the lacrimal passage. Openings are formed at both ends of the pair of tubes. A reinforcement body is disposed and held in the vicinity of each opening at a position located at a predetermined distance from the opening.08-23-2012
20100241048Systems, devices, and methods including infection-fighting and monitoring shunts - Systems, devices, methods, and compositions are described for providing an actively controllable shunt configured to, for example, monitor, treat, or prevent an infection.09-23-2010
20120136294Apparatus and Method for Treating Eustachian Tube Dysfunction - A method and apparatus for treating Eustachian tube dysfunction. The apparatus may include a tube with an aperture extending through the tube and a retention mechanism for retaining the tube in the Eustachian tube. The method may include endoscopically inserting the tube through the nasopharynx and into the Eustachian tube.05-31-2012
20110184330INACTIVATION OF SMOOTH MUSCLE TISSUE - Treatment and procedures for treating bodily conduits involves deactivating, killing, or otherwise treating smooth muscle tissue of the conduit.07-28-2011
20110184329Composite Arterial-Venous Shunt System - A novel composite arterial-venous (AV) shunt system is disclosed that resolves many known and persistent clinical problems associated with traditional synthetic AV shunts. The system comprises fluid-dynamically optimized non-porous anastomotic connectors with a non-porous self-sealing tubular shunt, and resolves clinical problems of leakage, infection, clotting due to turbulence, and cellular in-growth that can lead to stenosis.07-28-2011
20100241046APPARATUS, METHODS AND DEVICES FOR TREATMENT OF OCULAR DISORDERS - Apparatus and methods for relieving and treating glaucoma and other ocular disorders are disclosed. The apparatus includes a thin flexible membrane and preferably a tubular member. In another aspect of the invention, a surgical device for repairing ocular tissue includes a flexible membrane of a polymeric material comprising polyisobutylene. In the preferred embodiment, the polymeric material of the membrane is porous.09-23-2010
20100241047System, Methods and Apparatus for Cerebral Protection - A device, system and method for perfusing an oxygenated medium in the cerebral vasculature. In the case of bihemispheric brain perfusion, it includes positioning pressure cuffs on upper extremities; providing a catheter having a multi-region configuration with a balloon; inserting the catheter into a subclavian or femoral vein; advancing the catheter such that the balloon is positioned substantially in the superior vena cava junction substantially proximal to the take-off of the left innominate vein. During a perfusion mode, the cuffs and balloon are inflated causing an increase in cerebral blood flow, retrogradely; and oxygenated blood which may be cooled is pumped from a femoral artery into the catheter for a suitable period. During a non-perfusion mode the cuffs and balloon are deflated. The catheter has at least two regions, namely, guide wire and fluid delivery regions. Optionally, a separate balloon inflation region may be provided. In the case of unilateral (single hemisphere) brain perfusion, it includes providing a catheter having a multi-region configuration with a balloon, inserting the catheter into a subclavian, jugular or femoral vein, advancing the catheter such that the balloon is positioned in the internal jugular vein on the side ipsilateral to the side of the brain requiring perfusion. In this unilateral scenario where the balloon is inflated in the ipsilateral internal jugular vein, no pressure cuffs are needed and only the balloon is inflated and deflated during the perfusion and non-perfusion modes respectively.09-23-2010
20120220917OCULAR IMPLANT WITH HYDROGEL EXPANSION CAPABILITIES - An ocular implant includes an elongate member having an internal lumen forming a flow pathway that provides a fluid pathway between the anterior chamber and the suprachoroidal space of the eye. The implant includes a hydrogel member attached to the elongate member, wherein the hydrogel member is adapted to expand upon implantation of the elongate member in the eye. An attachment attaches the hydrogel member to the elongate member.08-30-2012
20120179086ANCHORS WITH OPEN HEADS - An implant (07-12-2012
20120179087Glaucoma Treatment Method - An ocular implant adapted to reside at least partially in a portion of Schlemm's canal of an eye. In some embodiments the implant has a body extending in a curved volume whose longitudinal axis forms an arc of a circle, and a plurality of open areas and strut areas formed in the body, the open areas extending over more than 50% of a surface defining the curved volume, the strut areas surrounding the open areas, the body having a diameter of between 0.005 inches and 0.04 inches. The invention also provides a method of treating glaucoma including the steps of supporting tissue forming Schlemm's canal in an eye with an implant extending at least partially in the canal along an axial length within the canal; and contacting with the implant less than 50% of the tissue forming the canal along the axial length.07-12-2012
20100010414METHOD OF DELIVERING AN IMPLANT FOR TREATING AN OCULAR DISORDER - Surgical methods and related medical devices for treating ocular disorders are disclosed. Some methods relate to delivering an implant within an eye, and involve providing an elongate guide device, such as, a flexible guide member or a guide wire. A distal end of the guide device can be advanced into an anterior chamber of an eye, or through at least a portion of a site of resistance along a physiologic outflow pathway of the eye, or from an anterior chamber of the eye to a location proximate a physiologic outflow pathway of the eye. The implant is advanced along the guide device toward the guide device distal end, and is positioned to conduct aqueous humor between the anterior chamber and the physiologic outflow pathway.01-14-2010
20120232458IMPLANTABLE SYSTEMS AND METHODS FOR REMOVING SPECIFIC IMPURITIES FROM FLUIDS SUCH AS BLOOD - Systems and methods utilize semipermeable nanotubes in conjunction with application of controlled electrical potentials across semipermeable nanotube walls allow selective transport of charged impurities (e.g., charged impurities, ions, etc.) from a fluid into these nanotubes. Impurities collected in these nanotubes can then be removed from the fluid, (e.g., blood) as a waste stream. A collection of semipermeable nanotubes each carrying a waste stream can be aggregated and merged into a ureter for excretion thereby providing an artificial kidney system. Sensors that detect/measure various impurities may be included in the system to feed information to a microprocessor to inform on concentrations of impurities, and thereby control electrical potentials applied to the system.09-13-2012
20110004146Systems and Methods for Treating of Obesity and Type 2 Diabetes - The present invention provides systems and methods for treating and controlling obesity and/or type II diabetes. In one aspect of the invention, a device comprises a hollow sleeve sized and shaped for positioning within a duodenum of the patient, an anchor coupled to the proximal end of the sleeve and being sized and shaped to inhibit distal migration of the sleeve and a plurality of elastomeric objects coupled to the distal end of the sleeve and being sized and shaped to inhibit proximal migration of the sleeve through a pylorus of the patient. The bypass device can be placed and removed endoscopically through the patient's esophagus in a minimally invasive outpatient procedure and it is “self-anchoring” and does not require invasive tissue fixation within the patient's GI tract, thereby reducing collateral tissue damage and minimizing its impact on the digestive process.01-06-2011
20120238936System, devices, and methods for real-time monitoring of cerebrospinal fluid for markers of progressive conditions - Systems, devices, methods, and compositions are described for providing real-time monitoring of cerebrospinal fluid for markers of progressive conditions.09-20-2012
20110028884OCULAR PRESSURE REGULATION - Disclosed are devices and methods of treating an ocular disorder including forming a self-sealing incision in a cornea into an anterior chamber of an eye; introducing through the incision a fluid drainage tube having a distal end, a proximal end and a longitudinal, internal lumen extending through the fluid drainage tube, wherein at least the proximal end passes through the anterior chamber; and implanting the distal end of the fluid drainage tube in fluid communication with the suprachoroidal space such that the proximal end of the fluid drainage tube remains in fluid communication with the anterior chamber.02-03-2011
20120323159Ocular Implants for Delivery Into the Eye - An ocular implant adapted to reside at least partially in a portion of Schlemm's canal of an eye. The implant includes a spine extending along a longitudinal axis of the implant, a plurality of curved supports extending from the spine, each support comprising a first end extending from a first location on a first side of the spine and a second end extending from a second location on a second side of the spine, the second location being proximal to the first location, so that each support forms a portion of a helix, the spine and supports defining a volume having a maximum width perpendicular to the longitudinal axis between 0.005 inches and 0.04 inches, the ocular implant being configured to bend preferentially in a preferential bending plane.12-20-2012
20090024071U-Shaped Disc Shunt and Delivery Device - The intervertebral disc contains no blood vessels. Nutrients and waste are diffused mainly through adjacent vertebral bodies. As we age, calcified layers form between the disc and vertebral bodies, blocking diffusion. The disc begins to starve and flatten. The weight shifts abnormally from disc to the facet joints causing strain and back pain. Under anaerobic conditions, lactic acid is produced causing acidic irritation and unspecific pain. A U-shaped disc shunt (01-22-2009
20110046537Systems and Methods for Treatment of Obesity and Type 2 Diabetes - The present invention provides systems and methods for treating and controlling obesity and/or type II diabetes. In one aspect of the invention, a device comprises a hollow sleeve sized and shaped for positioning within a duodenum of the patient, an anchor coupled to the proximal end of the sleeve and being sized and shaped to inhibit distal migration of the sleeve and a plurality of elastomeric objects coupled to the distal end of the sleeve and being sized and shaped to inhibit proximal migration of the sleeve through a pylorus of the patient. The bypass device can be placed and removed endoscopically through the patient's esophagus in a minimally invasive outpatient procedure and it is “self-anchoring” and does not require invasive tissue fixation within the patient's GI tract, thereby reducing collateral tissue damage and minimizing its impact on the digestive process.02-24-2011
20110046536METHOD AND DEVICE FOR THE TREATMENT OF GLAUCOMA - The invention relates to a method and device for the treatment of glaucoma, though insertion of an implant into the lumen of the Schlemm's canal to realize proper drainage of the aqueous humor, which implant is brought into its position in the Schlemm's canal by means of a catheter having a distal and a proximate portion and provided with a number of pores through which a gaseous or fluid medium which comes from a pressure source can emerge during insertion of the catheter carrying the implant into the Schlemm's canal, and while the catheter is being inserted into the Schlemm's canal the gaseous or fluid medium is released under pressure thereby expanding the Schlemm's canal and the implant and upon releasing the implant at its determined location, the catheter can be withdrawn from the Schlemm's canal.02-24-2011
20120271217SATIATION DEVICES AND METHODS - A device for inducing weight loss in a patient includes a tubular prosthesis self-expandable from a collapsed position in which the prosthesis has a first diameter to an expanded position in which the prosthesis has a second, larger, diameter. In a method for inducing weight loss, the prosthesis is placed in the collapsed position and inserted into a stomach of a patient. The prosthesis is allowed to self-expand from the collapsed position to the expanded position and into contact with the walls of the stomach, where it induces feelings of satiety and/or inhibits modulation of satiety-controlling factors such as Ghrelin.10-25-2012
20100234793Systems, devices and methods including infection-fighting and monitoring shunts - Systems, devices, methods, and compositions are described for providing an actively controllable shunt configured to, for example, monitor, treat, or prevent an infection.09-16-2010
20100234792Systems, devices, and methods including infection-fighting and monitoring shunts - Systems, devices, methods, and compositions are described for providing an actively controllable shunt configured to, for example, monitor, treat, or prevent an infection.09-16-2010
20100234791DUAL DRAINAGE PATHWAY SHUNT DEVICE - A shunt is provided for the flow of aqueous humor from the anterior chamber of the eye to Schlemm's canal and to other anatomical spaces of the eye. The shunt comprises at least one lumen and optionally has at least one anchor extending from a proximal portion of the shunt to assist in placement and anchoring of the device in the correct anatomic position.09-16-2010
20100234790OCULAR IMPLANT WITH THERAPEUTIC AGENTS AND METHODS THEREOF - Implants and methods for treating ocular disorders are provided. One method involves introducing an implant into an anterior chamber of an eye such that at least a distal end of the implant is temporarily in the anterior chamber. The implant is implanted into eye tissue adjacent the anterior chamber. A therapeutic agent is eluted from the implant into at least one of the anterior chamber, a physiologic outflow pathway of the eye, and a space adjacent a choroid of the eye. The therapeutic agent can be an antiproliferative agent, an anti-inflammatory drug, or a compound for treating glaucoma or ocular hypertension. The therapeutic agent can be contained within the implant or coated on the implant.09-16-2010
20100234789SELF ADJUSTING VENOUS EQUALIZING GRAFT - A self adjusting venous equalizing graft (SAVE graft) which provides a self regulating stenosis is provided herein. The SAVE graft responds to increases or decreases in blood pressure which allows a higher pressure at the graft's arterial end and a lower pressure at the graft's venous end. This is ideal in that it mimics the natural pressure of a patient's circulatory system. A dialysis machine may draw blood at the arterial end, dialyze the blood, and return the blood to the patient at the graft's venous end. The lower pressure at the venous end prevents damage to the patient's vein. The SAVE graft may comprise a deformable stenosis control diaphragm or a venous controlled pressure nozzle which may expand or contract in response to blood pressure to self regulate the stenosis provided by the SAVE graft.09-16-2010
20120089071IMPLANT DEVICE, TOOL, AND METHODS RELATING TO TREATMENT OF PARANASAL SINUSES - An implant device is configured to be implanted in a fistula to fluidly connect the lacrimal apparatus and a paranasal sinus. A surgical tool has an implant the implant device mounted on a carrier. Various methods involve a fistula between the lacrimal apparatus and a paranasal sinus. A kit includes an entry device for use to form a fistula and an implant tool for use to implant an implant device following formation of a fistula.04-12-2012
20110295179METHODS AND DEVICES FOR REGULATING THE ACTIVATION OF GHRELIN HORMONES WITHIN A STOMACH - Methods and devices regulate the activation of ghrelin hormones within a stomach in order to treat weight disorders, to promote learning and memory functions, to treat stress-induced depression, and to control sleep duration. In one embodiment, a method for regulating activation of ghrelin hormones within a stomach comprises a means for isolating non-activated ghrelin hormones from food content and dietary lipids within the stomach. These means for isolating may take any number of forms and may comprise one or more of a surgical procedure, an implanted device, or an ingestible substance.12-01-2011
20110319806Ocular Implants Deployed in Schlemm's Canal of the Eye - An ocular implant is provided that is adapted to reside at least partially in a portion of Schlemm's canal of an eye. The implant includes an implant body having plurality of filars extending along a longitudinal axis of the implant. The implant is configured to move between a radially collapsed state and a radially expanded state. In some embodiments, the implant is configured to assume the radially expanded state when no external forces are acting thereon. Methods of delivering and using the ocular implant are also provided.12-29-2011
20130018296OCULAR IMPLANT WITH THERAPEUTIC AGENT AND METHODS THEREOF - An ocular disorder treatment implant includes an anchor and a therapeutic agent. The implant has a body with first and second end portions. The implant is configured to transport fluid from the anterior chamber of an eye to a physiological outflow pathway of the eye. The body has at least one inlet opening at the first end portion and at least one outlet opening at the second end portion such that the inlet and outlet openings are in fluid communication and define an axis therebetween. The anchor extends substantially perpendicularly to a part of the axis between the openings, and at least one outlet opening is configured to be positioned in the physiological outflow pathway. One implant has two outlet openings, and the anchor is disposed closer to one of the outlet openings.01-17-2013
20130018295OCULAR IMPLANT WITH ANCHORING MECHANISM AND MULTIPLE OUTLETS - Devices and methods for treating ocular disorders are disclosed. One ocular implant, has a substantially straight, rigid, elongate body. The body has a self-trephinating distal portion that narrows toward a distal end, and at least one inlet that communicates with at least one inner lumen that communicates with a plurality of outlets. The lumen has a sufficient length to extend from an anterior chamber of an eye to a physiologic outflow pathway. An anchor member extends from the implant.01-17-2013
20130023813Drug Delivery Device and Method - Many people need vascular access for procedures such as hemodialysis. It is desirable that this access remain open or patent for the entire duration of the course of treatments. A drug delivery device and methods of using the device are introduced that delivery drug to venous anastomosis of a synthetic vascular access shunt. In some embodiments this device serves as the shunt connecting the target artery and vein to create the vascular access shunt.01-24-2013
20080249458Intraventricular Shunt and Methods of Use Therefor - Methods and apparatus for treating hydrocephalus caused by obstructions in the ventricular system and subarachnoid space of the brain. Embodiments include medical devices and methods for use within the subarachnoid space of the central nervous system to gain access to and treat an obstruction within the ventricles of the brain or a subarachnoid hemorrhage. The obstruction may be aspirated by an aspiration catheter for use in the subarachnoid space. A subarachnoid delivery catheter may then be used to deliver an intraventricular shunt to the opening in the obstruction via the subarachnoid space. A distal end of the delivery catheter is navigated across the obstruction to deploy the intraventricular shunt therein. The intraventricular shunt so positioned reopens the pathway between the ventricles and permits the return of normal cerebrospinal fluid flow there through.10-09-2008
20130172804Glaucoma Treatment Method - An ocular implant adapted to reside at least partially in a portion of Schlemm's canal of an eye. In some embodiments the implant has a body extending in a curved volume whose longitudinal axis forms an arc of a circle, and a plurality of open areas and strut areas formed in the body, the open areas extending over more than 50% of a surface defining the curved volume, the strut areas surrounding the open areas, the body having a diameter of between 0.005 inches and 0.04 inches. The invention also provides a method of treating glaucoma including the steps of supporting tissue forming Schlemm's canal in an eye with an implant extending at least partially in the canal along an axial length within the canal; and contacting with the implant less than 50% of the tissue forming the canal along the axial length.07-04-2013
20130178782METHODS AND DEVICES FOR DELIVERING OR DELAYING LIPIDS WITHIN A DUODENUM - Devices and methods described include a flow reduction device adapted and configured for use within the duodenum of a mammal having a spine, a first atraumatic feature, a second atraumatic feature, and a flow reduction element having a proximal end, a distal end, an interior portion, an exterior portion and a variable porosity between the proximal end and the distal end. One aspect of the device includes a spine having a proximal end and a distal end, an atraumatic feature positioned on at least one of the proximal end and the distal end of the spine, and a flow reduction element positioned along the spine and having a variable porosity along its length.07-11-2013
20110270148PERCUTANEOUS COLLATERAL BYPASS - A bypass provided by a bypass conduit disposed in a vessel which is collateral to an occluded vessel. The bypass conduit comprises a helical wire body having a plurality of connectors connecting adjacent turns of the helical body.11-03-2011
20130096482ALTERNATE GEOMETRY STYLET FOR VENTRICULAR SHUNT CATHETER PLACEMENT - A stylet having a non-round cross-sectional shape which is specifically adapted to reduce the adhesion or “stickiness” of contact between the stylet and the interior surface of the lumen of an elastomeric catheter through which it extends. The stylet may be “pre-loaded” into the catheter.04-18-2013
20130102950Graft-Catheter Vascular Access System - A vascular access device, for implantation at least partially below the skin of a patient to provide an arteriovenous fistula, includes a graft portion coupled to a catheter portion. The graft portion is sutured to an opening in an artery while the catheter portion is inserted into a vein so that its end lies within the vein downstream from the point of entry into the vein. The device may be comprised of ePTFE with an outer polyurethane coating or the graft portion may comprise ePTFE with an outer polyurethane coating and the catheter portion may comprise polyurethane. There may also be an inner polyurethane coating. Alternatively, the device may be comprised entirely of polyurethane.04-25-2013
20130102949GLAUCOMA DRAINAGE SHUNTS AND METHODS OF USE - A method of treating glaucoma in an eye utilizing an implanted shunt having an elastomeric plate and a non-valved elastomeric drainage tube. The plate is positioned over a sclera of the eye with an outflow end of the elastomeric drainage tube open to an outer surface of the plate. An inflow end of the drainage tube tunnels through the sclera and cornea to the anterior chamber of the eye. The drainage tube collapses upon initial insertion within an incision in the sclera and cornea, or at a kink on the outside of the incision, but has sufficient resiliency to restore its patency over time. The effect is a flow restrictor that regulates outflow from the eye until a scar tissue bleb forms around the plate of the shunt. The plate desirably has a peripheral ridge and a large number of fenestrations, and a longer suturing tab extending from one side of the plate to enhance visibility and accessibility when suturing the shunt to the sclera.04-25-2013
20110313340UNOBSTRUCTING MICRODEVICES FOR SELF-CLEARING IMPLANTABLE CATHETERS - A self-clearing actuator configured to be positioned in a pore providing fluid communication into a central lumen of a ventricular catheter body is described. The actuator extends into a central bore via a cantilever beam having a first end emanating at the central bore and a second end terminating at the actuator, wherein the actuator is configured to reciprocate within the central bore between a first position extending downward at an angle into the central bore and a second position substantially at or above the external surface of the catheter. The cantilever beam is stressed, e.g. via a composite compress layer, such that it is preloaded to nominally curve downward to extend the actuator into the second position. The actuator is preferably a magnet responsive to magnetic field such that the magnetic field drives the actuator toward the first position.12-22-2011
20130158462Delivering Ocular Implants Into the Eye - A method of deploying an ocular implant into Schlemm's canal of an eye. The method includes the steps of inserting a distal end of a cannula through a cornea of the eye and into an anterior chamber of the eye, the cannula having a distal opening extending from the distal end and through a side wall; placing the distal opening of the cannula into fluid communication with Schlemm's canal; advancing the ocular implant distally through the cannula with a delivery tool engaged with the ocular implant, a proximal portion of the ocular implant engaging the delivery tool proximal to a distal portion of the delivery tool; and disengaging the ocular implant and the delivery tool when the proximal portion of the ocular implant reaches the cannula distal opening. The invention also includes a system for practicing the method.06-20-2013
20130158464SELF CLEANING SHUNT - A self cleaning inlet head for use on a shunt. The head has a tube with openings disposed in predetermined positions in its wall, and a cleaning element installed inside the tube. The cleaning element may comprise a central shaft with a number of bristles protruding therefrom, preferably in locations substantially identical to the positions of the openings in the wall of the tube. Mutual vibratory motion between the cleaning element and the tube causes at least some of the bristles to enter the openings, thereby keeping them clear, and preventing tissue growth into them. The vibratory motion may be generated by the action of an external field on a responsive part of the cleaning element, such as an external magnetic field operating on a magnetic or magnetized part of the cleaning element or the bristles. Alternatively, the external field may be an ultrasound field operating on the bristles.06-20-2013
20130158463SYSTEMS AND METHOD FOR BYPASSING AN ANASTOMOSIS SITE - A system for bypassing an anastomosis site in a hollow organ is provided. The system includes a sleeve configured for spanning the anastomosis site at an internal surface of the hollow organ and a band configured for attachment to an external surface of the hollow organ and limiting migration of the sleeve beyond the anastomosis site.06-20-2013
20080200860SYSTEM FOR TREATING OCULAR DISORDERS AND METHODS THEREOF - Systems and methods for treating ocular disorders are disclosed. One system has an implant and a delivery device. The implant has inlet and outlet portions, a lumen extending therebetween and communicating with inlet and outlet ports. The implant is sized so that in use aqueous humor flows from an anterior chamber of an eye through the implant and into a uveal scleral outflow path of the eye. The delivery device is configured to advance the implant from within the anterior chamber, with the outlet portion leading the inlet portion, to a location where the outlet and inlet ports respectively communicate with the uveal scleral outflow path and the anterior chamber. One method involves advancing an implant from within the anterior chamber, and draining fluid from therein such that fluid flows into an implant inlet port and out through an implant outlet port and into the uveal scleral outflow path.08-21-2008
20110224595SYSTEM FOR REGULATING INTRACRANIAL PRESSURE - The present invention relates to a method and system to regulate pressure in an object, and is especially suitable for regulating intracranial pressure in people suffering from hydrocephalus. The system includes the measurement of physical parameters other than the pressure to be regulated, especially the present position of the object, such as the inclination.09-15-2011
20100286586SYSTEM AND METHOD FOR SITE SPECIFIC THERAPY - A system, including catheter apparatus, and related method for performing site specific therapy. The catheter apparatus can include one or more semipermeable microcatheters for use in performing site specific microdialysis. The system and method are particularly suited for use in addressing cerebral edema by affecting the osmolar relationship between fluids making up the brain tissue.11-11-2010
20100286585Shunt Delivery of Curcumin - A method for reducing or preventing a human brain disorder relating to the presence of a pathogenic substance in cerebrospinal fluid by selecting a human for treatment as a patient and placing a proximal end of a first catheter, having at least a first lumen, in a first sub-dural location within the brain of the patient to establish open communication between the first lumen and cerebrospinal fluid of the patient. For an extended period of time, a curcumin agent selected from at least one of curcumin, a curcumin hybrid and a curcumin analog is delivered to the cerebrospinal fluid to interact with the pathogenic substance to attenuate its effect on the brain.11-11-2010
20110275975ANTI-THROMBOGENIC VENOUS SHUNT METHOD - A venous shunt method adapted to shunt cerebral spinal fluid in a patient. A fluid control device having a fluid passage is adapted to be placed allowing cerebral spinal fluid to flow through the fluid passage. A catheter having a lumen, the catheter being in fluid communication with the fluid control device. At least a portion of at least one of the catheter and the fluid control device being subjected to an anti-thrombogenic treatment.11-10-2011
20130150770METHODS FOR PLACING A SHUNT INTO THE INTRA-SCLERAL SPACE - The present invention generally relates to intraocular shunts, and in particular, to intraocular shunts configured to form a drainage pathway between the anterior chamber and the intra-scleral space.06-13-2013
20130150771System and Method For Powering Ocular Implants - A system for treating an ocular condition of a patient includes an electrically powered ocular implant sized for placement within an eye and includes a transmitter sized to be carried on or adjacent the head of the patient for disposal adjacent the eye. The transmitter includes a transmission antenna that emits an electromagnetic flux field sufficient to energize the ocular implant and includes a flux shunt disposed within the electromagnetic flux field. The transmission antenna may be disposed between the flux shunt and the implant.06-13-2013
20130150772BY-PASS SHUNT TO REDUCE FLOW OUTPUT OF CIRCULATORY ASSIST DEVICE - A by-pass shunt for use with a bodily fluid pump. The by-pass shunt includes an inflow conduit, an outflow conduit, and an intermediate conduit fluidically coupling the inflow and outflow conduits. A flow restrictor is operably coupled to a portion of the intermediate conduit and is configured to reduce a fluid flow from the outflow conduit, through the intermediate conduit, and into the inflow conduit.06-13-2013
20120259263APPARATUS AND METHODS TO CREATE AND MAINTAIN AN INTRA-ATRIAL PRESSURE RELIEF OPENING - The present disclosure relates to a method and a device for treating heart failure by normalizing elevated blood pressure in the left and right atria of a heart of a mammal The present disclosure includes methods for creating and maintaining an opening in the atrial septum. Tools for making an opening and enlarging the opening are also disclosed. Use of the techniques and tools described herein prolongs the patency of an intra-atrial pressure relief opening.10-11-2012
20100318016Methods and Compositions for Enhancing Vascular Access - Disclosed is an implantable material comprising a biocompatible matrix and cells which, when provided to a vascular access structure, can promote functionality generally. For example, implantable material of the present invention can enhance maturation of an arteriovenous native fistula as well as prolong the fistula in a mature, functional state suitable for dialysis. Additionally, the present invention can promote formation of a functional arteriovenous graft suitable for dialysis as well as promote formation of a functional peripheral bypass graft. Implantable material can be configured as a flexible planar form or a flowable composition with shape-retaining properties suitable for implantation at, adjacent or in the vicinity of an anastomoses or arteriovenous graft. According to the methods disclosed herein, the implantable material is provided to an exterior surface of a blood vessel. Certain embodiments of the flexible planar form define a slot. The materials and methods of the present invention comprise cells, preferably endothelial cells or cells having an endothelial-like phenotype.12-16-2010
20100318015DEVICES, SYSTEMS, AND METHODS FOR ACHIEVING MAGNETIC GASTRIC BYPASS - Devices, systems and methods are disclosed for the treatment of obesity. A magnetic device is provided that enables the creation of a Roux limb without the use of staples or sutures. Additionally, a magnetic device is described for extending the length of the Roux limb such that tension in the stomach and/or the intestines is prevented. Further, a system and method are described for achieving the reversible restriction of gastric capacity and bypass of the duodenum without the use of sutures or staples.12-16-2010
20130184631Method, Surgical Kit and Device for Treating Glaucoma - A surgical kit includes at least one instrument and at least one implant device. The instrument has a needle body used to form a surgical passage through ocular tissue. The device includes a flexible tube that defines a duct for diverting aqueous humor with an outer surface having a maximal cross-sectional dimension that is less than the maximal cross-sectional dimension of the needle body. The device incorporates sealing means including at least one element that define a maximal cross-sectional dimension that is greater that the maximal cross-sectional dimension of the needle body and that are operably disposed within the surgical passage and form a seal between the surrounding ocular tissue and the element(s) as well as fixate the device in the surgical passage. The kit (and devices thereof) can be used as part of a surgical method to divert aqueous humor to a space formed in ocular tissue.07-18-2013
20110306914ENDOSCOPIC DELIVERY DEVICE - An endoscopic or laparoscopic conduit delivery device (12-15-2011
20130190675Methods and Devices for Treating Alzheimer's Disease - A method and apparatus of treating Alzheimer's disease in an individual. In one embodiment, the method includes bypassing a portion of the gastrointestinal tract of the individual. In another embodiment, the method includes modifying insulin levels or insulin resistance in the brain of an individual with Alzheimer's disease or predisposed to Alzheimer's disease. In still yet another embodiment, the bypass causes the individual's serum levels of GLP-1 protein to increase.07-25-2013
20130190676DEVICES AND METHODS FOR FLUID FLOW THROUGH BODY PASSAGES - A device includes a first end portion, a second end portion, an intermediate portion between the first end portion and the second end portion, and a graft material coupled to at least the intermediate portion. The first end portion has a first end diameter. The second end portion has a second end diameter larger than the first end diameter. The intermediate portion tapers between the first end portion and the second end portion. A method of diverting fluid flow from a first passage to a second passage comprising deploying the device in a third passage between the first passage and the second passage, expanding the first end portion against sidewalls of the first passage, and expanding the second end portion against sidewalls of the second passage.07-25-2013
20120004589DELIVERING A CONDUIT INTO A HEART WALL TO PLACE A CORONARY VESSEL IN COMMUNICATION WITH A HEART CHAMBER AND REMOVING TISSUE FROM THE VESSEL OR HEART WALL TO FACILITATE SUCH COMMUNICATION - Devices and methods for delivering conduits into the wall of a patient's heart to communicate a coronary vessel with a heart chamber. The devices are passed through the coronary vessel and the heart wall to place the conduit and establish a blood flow path between the vessel and the heart chamber. Additional devices and methods are provided for removing tissue from a coronary vessel or the heart wall to establish a flow path between the coronary vessel in communication with the heart chamber.01-05-2012
20120029413GASTROINTESTINAL IMPLANT WITH DRAWSTRING - A gastrointestinal implant device includes a flexible, floppy sleeve, open at both ends, that extends into the duodenum. The device further includes a collapsible anchor coupled to the proximal portion of the sleeve. The device further includes a drawstring that is threaded through a proximal end of the anchor, and barbs that extend from the exterior surface of the anchor. The collapsible anchor can be a wave anchor. The drawstring can be used to collapse at least a proximal portion of the implant device. This is useful in removing or repositioning the implant device.02-02-2012
20120029412INTERNAL AND EXTERNAL DISC SHUNT ALLEVIATE BACK PAIN - The intervertebral disc is avascular. Nutrients and waste are diffused through adjacent vertebral bodies into the disc. As we age, calcified layers form between the disc and vertebral bodies, blocking diffusion of nutrients, oxygen and pH buffer in blood. Under anaerobic conditions, lactic acid is produced, irritating nerve endings and causing nonspecific pain. In addition, the disc begins to starve and flatten. The weight shifts abnormally from disc to the facet joints causing strain and back pain. Shunt coils are formed and spiraled over the distal shaft of a twistable needle, then deployed into the nucleus of a degenerated disc by a sliding sleeve. The coils serve as an internal shunt, drawing nutrients, oxygen and buffering solute from the superior and inferior diffusion zones to neutralize lactic acid in the mid layer of the degenerated disc. The coils also serve as a bulking agent within the repaired disc to sustain compression and reduce facet loading and segmental instability. The end strands of the shunt coils can also extend from the disc to draw blood plasma from muscle or bodily circulation to expedite neutralization of lactic acid and rebuild disc matrix for pain relief and disc regeneration.02-02-2012
20120029411CARPAL TUNNEL DRAINAGE - A procedure for treating carpal tunnel syndrome can involve aspirating one or more of the flexor tendons running through the carpal tunnel to reduce swelling, and hence reduce the cross-sectional area of those flexor tendons. As a result, the median nerve also running through the carpal tunnel is less constricted, and the CTS symptoms associated with such constriction can be relieved. Such relief can be enhanced by delivery of one or more therapeutic substances to the area to provide additional or supplemental symptom treatment.02-02-2012
20130197421PANCREATICOBILIARY DIVERSION DEVICE - Apparatus (08-01-2013
20130204175DEVICES AND METHODS FOR TREATING HEART FAILURE - The present teachings provide a device and method of making and using thereof. Specifically, one aspect of the present teachings provides a device comprising a shunt having a distal end and a proximal end and the shunt positionable across the septum of a heart. Certain embodiments of the present teachings also include a distal anchoring portion connecting to the distal end of the shunt portion and a proximal anchoring portion connecting to the proximal end of the shunt portion. Another aspect of the present teachings provide methods of using thereof to modify the pressure difference in a heart chamber.08-08-2013
20120065571EXPANDABLE PYLORIC ANCHORS AND METHODS FOR SECURING INTESTINAL BYPASS SLEEVES - A gastrointestinal device for implanting within a patient's gastrointestinal tract includes first and second expandable anchoring rings configured to be disposed on either side of a patient's pylorus. The first expandable anchoring ring has a collapsed configuration and an expanded configuration, wherein in the expanded configuration the first expandable anchoring ring has a diameter larger than a maximum opening diameter of the pylorus. The second expandable anchoring ring also has a collapsed configuration and an expanded configuration, wherein in the expanded configuration the second expandable anchoring ring has a diameter larger than a maximum opening diameter of the pylorus. An intestinal bypass sleeve couples the first expandable anchoring ring and the second expandable anchoring ring, so as to allow a distance between the anchoring rings to exceed a width of the pylorus.03-15-2012
20120095383SYSTEMS AND METHODS FOR AN ADVANCED MEDICAL DEVICE - The present invention relates to a biologically active medical device, which includes a matrix seeded with progenitor cells, and then covered by ciliated tissue. The matrix is capable of enabling cellular migration. The ciliated tissue is ependymal cells that express at least one of tight junctional complexes, zonula adherens, and gap junctions. The progenitor cells include subpendymal progenitor cells. In some cases the progenitor cells include stem cells, and the ciliated tissue includes at least one of Choroid cells, tanacytes, and circumventricular organs. In some embodiments, the medical device is oriented into a tubular structure in order to form a cerebrospinal shunt. Additional cells and structures may be imbedded within the matrix, such as glia, endothelial cells, stem cells, and blood vessels. The medical device may also be incorporated into a bioreactor including a flexible inner tube defining an anthropomorphically shaped lumen.04-19-2012

Patent applications in class DEVICES TRANSFERRING FLUIDS FROM WITHIN ONE AREA OF BODY TO ANOTHER (E.G., SHUNTS, ETC.)

Patent applications in all subclasses DEVICES TRANSFERRING FLUIDS FROM WITHIN ONE AREA OF BODY TO ANOTHER (E.G., SHUNTS, ETC.)